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Abstract 




Joint Doctor of Philosophy 
with the University of California, San Francisco in Bioengineering  
University of California, Berkeley 
Professor Michel M. Maharbiz, Chair  
Molecular detection and analysis are of fundamental importance in disease prevention, 
disease diagnosis, medical treatment, drug delivery, food industry, and environmental monitoring. 
Conventional immunoassays require hours of incubation for low concentration analytes 
(femtomolar) since the rate-limiting step is the transport of target molecules to the biosensors. 
Thus, a new technology for fast and sensitive immunoassay is highly desirable for disease 
monitoring and personalized treatments. The work reported in this thesis is focused on developing 
silicon microfabrication technologies for sensors that can detect low concentration proteins 
(femtomolar) in a short time (tens of minutes).  
 
We first demonstrate the use of germanium (Ge) films as sacrificial layers that allow the 
patterning of proteins onto surfaces with commonly used organic solvents. As researchers 
miniaturize biosensors and microfluidic devices down to submicron scales, high-resolution 
biomolecule conjugation compatible with these processes is highly desirable. The presented 
technique is scalable to high volume manufacturing and is compatible with nano- and 
microfabrication processes, including standard lithography. We achieved nanoscale resolution and 
misalignment with this technique.  
 
We then discuss the development of ICP-based preconcentration devices on silica and 
silicon substrates. We report two nanofabrication strategies in this chapter that enhance the 
accumulation of protein molecules via 1) an increase in the number of nanochannels per 
microchannel and 2) an increase in the depth of nanochannels. Increasing the depth of 
nanochannels leads to the switch from silica substrates to silicon substrates, using deep reactive 
ion etch (DRIE). We also report the attempts for antibody immobilization in the ICP 
preconcentrators using previously reported Ge technique. However, due to the instability of 
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antibodies in the drying process, we switched to bead-based immunoassays in our preconcentration 
devices.  
 
After the demonstration of protein preconcentration in our devices, we present a scalable 
method for fabricating hundreds of vertical nanochannels (6.5 µm deep) employing ion 
concentration polarization (ICP) enrichment for fast analyte detection. Compared to horizontal 
nanochannels, massively paralleled vertical nanochannels not only provide comparable 
electrokinetic functions but also significantly reduce effective fluid resistance in each microfluidic 
channel, which enables microbead loading for sensing purposes.  These nanochannels filter 
microbeads by size and preconcentrate analytes at the anodic side of the test area via electrokinetic 
entrapment. The device is capable of enriching protein molecules by >1000 fold in 10 min. We 
demonstrate fast detection of IL6 down to 7.4 pg/ml with only a 10 min enrichment period 
followed by a 5 min incubation, which is a 162-fold enhancement in sensitivity compared to that 
without enrichment. Our results demonstrate the possibility of using silicon/silica-based vertical 
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Chapter 1: Introduction 
 
1.1 Micro/nanofluidic preconcentration is important for 
biosensing 
 
Molecular detection and analysis are of fundamental importance in disease prevention, 
disease diagnosis, medical treatment, drug delivery, food industry, and environmental 
monitoring.[1–4] With advances in microfabrication technologies, miniaturized biosensors have 
been developed and integrated into microfluidic platforms. These microfluidic biochips have 
numerous advantages over traditional benchtop devices, including faster detection speeds, lower 
costs, higher sensitivities, less sample volume needed, and greater suitability for portable devices. 
Thus, miniaturized biosensors have attracted much interest in the past two decades [2,5–8]. 
 
In order to perform a reliable and accurate detection of a diffusible analyte, that analyte’s 
concentration must be higher than a putative sensor’s lower limit of detection (LOD). However, 
for many biosensing applications this can be very difficult. Examples include sensing analytes for 
the diagnosis of early stage cancers [9,10] and the detection of  heavy metals that are lethal at low 
concentration [11], among others. When the analyte concentrations are extremely low 
(femtomolar), the rate-limiting step is the analyte transport to the biosensors [12–15]. For example, 
Ying-Chih Wang et al. (2008) showed that the equilibrium time of R-phycoerythrin (R-PE) capture 
by an antibody increases significantly as concentration decreases [16]. For this reason, many 
sensing methods make use of prolonged incubation times (> several hours) when detecting low 
concentration analytes - especially when the target concentration is lower than the antibody 
dissociation constant.  
 
However, some applications demand faster detection times (< 1 hr). A very important 
example is the detection of sepsis in human patients. Sepsis is the tenth leading cause of death in 
developed countries [17]. Sepsis arises when the body’s own immune response to an insult (like 
infection or injury) is so acute that it leads to tissue damage and if untreated, eventually organ 
failure and death. Despite a small decline in mortality rate, the total number of patients dying from 
sepsis is still growing due to antimicrobial resistance, the growing elderly population, the wider 
use of immunosuppressive therapies, and more invasive medical technologies [18]. Cytokines are 
the critical chemical signaling mediators and biomarkers for inflammatory diseases such as sepsis. 
Cytokine concentrations are significantly correlated with septic patient mortality rate and can be 
used for sepsis diagnosis [19–21]. Septic patients’ survival rate decreases by 8% for each hour 
delay of treatment [22], so these patients have to be treated immediately. However, conventional 
cytokine detections take hours if not days due to their low concentrations (femtomolar). Thus,  a 
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new technology for biomolecular detection, which is fast and highly sensitive, is highly desirable 
for cytokine level monitoring to open the door to patient-specific treatment [23,24].   
 
Many assays have been developed for biosensing at low concentrations via signal 
amplification and/or high-sensitivity sensors, such as optical microcavity-based assays[25], 
magnetic bead-based assays [10,26], cantilever-based biosensors [27–30], nanowire-based 
immunoassays [31–34], graphene-enhanced immunoassays [35–39], and surface plasmon 
resonance-based analyte detections [40–44]. However, most of these technologies rely on high-
quality antibodies (low dissociation constant) and/or require lengthy incubation times. Therefore, 
fast detection for low abundance analytes remains a challenge.   
 
Another approach for rapid and sensitive detections is analyte preconcentration. The 
simplest method for analyte enrichment is physical filtration, in which large analytes are size-
excluded from the filter [45,46]. However, physical filtration membranes have clogging issues and 
low recovery rate. There are many sample preconcentration devices based on electrokinetic 
phenomena, including amplification stacking [47–50], isoelectric focusing [51–54], 
dielectrophoresis [55–58], and isotachophoresis [59]. Of these various techniques, 
micro/nanofluidic analyte enrichment using ion concentration polarization (ICP) has attracted a lot 
of attention because of its high enrichment factor (up to 106 fold) [60]. Besides the enrichment 
factor, ICP-based preconcentration has following three major advantages: 1) no need for special 
buffers or reagents; 2) uses only DC voltages, so the instruments are much simpler (compared to 
dielectrophoresis); 3) preconcentrates charged molecules regardless of their sizes. Due to these 
advantages, ICP-based enrichment has been applied to a lot of different analytes such as cells, 
protein, DNA, metal ions, and other small molecules [1].  
 
1.2 Foundations of ICP-based preconcentration 
 
1.2.1 Mechanism of ICP-based preconcentration 
As we discussed above, analyte enrichment is highly desirable to enhance the LOD of 
biomolecule detection. ICP effect is one of the most commonly used methods for the 
preconcentration of charged analytes [1,3,61].  The ICP phenomenon usually appears at the 
junction region between microchannels and nanochannels (or perm-selective membranes). These 
nanochannels allow counter-ions to pass across, while most of the co-ions are blocked by 
electrostatic repulsion. This phenomenon is called ion-selectivity (or perm-selectivity), which is 
the key to generating ICP.  
 
For the case of negatively charged microchannels and nanochannels (or perm-selective 
membranes), electroosmotic flow (EOF) carries the bulk solution from the anode to the cathode 
under DC voltages. Due to the cation selectivity of the nanochannels (or membranes), more cations 
(counter-ions) are transported through these nanochannels than anions (co-ions), resulting in the 
formation of ion depletion at the anodic side of the nanochannels (Fig 1.1 a). The depletion zone 
has very low concentration of ions and therefore induces a large electric field. The amplified 
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electric field in the depletion zone repels negatively charged molecules (including negatively 
charged analytes) toward the anode by electrophoretic force (Fig 1.1b). In addition, the low ionic 
strength in the depletion zone induces non-equilibrium space charge layers, which in turn results 
in the accelerated non-equilibrium EOF (EOF of the 2nd kind). The non-equilibrium EOF in the 
depletion zone has a much higher velocity than the EOF in the bulk solution. Since the fluid is 
incompressible, strong vortical flows are generated in the depletion zone (Fig 1.1c).  
 
 
Fig 1.1 The mechanism of ICP in front of nanostructures.  
The anode is on the left side of the nanostructure. (a) The negatively charged nanochannels 
transport more cations than anions. (b) The additional cations transported by surface 
conduction initiate a weak concentration polarization and decrease ion concentration on the 
anodic side of the nanochannels. The lower ionic strength increases the thickness of local 
electrical double layers (EDL), which enhances permselectivity of nanochannels. This positive 
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feedback promotes a strong concentration polarization even when the Debye length is 
significantly shorter than the nanochannel width. (c) The depletion zone induces 
nonequilibrium space charge layers and generates nonequilibrium EOFs near nanochannels, 
which induces vortical flow. The backwards fluid flows along with the amplified electric field 
in depletion zone move analytes (negatively charged) upstream until the convection and 
electromigration balance, resulting in analyte enrichment.   
 
 
The force analysis of analytes is shown in Fig 1.2. When the negatively charged analytes 
are far from the nanostructures, the dragging force of EOF (1st kind) is dominant and brings 
analytes toward the nanostructures (Fig 1.2a). When the negatively charged analytes are in the 
depletion zone, the amplified electrophoretic force (electromigration) and the dragging force from 
the back flow of the vortical flow (EOF of the 2nd kind) become larger than the EOF of the 1st kind, 
bringing analytes upstream (Fig 1.2b). Thus, the backflow of the circulation flows and the 
amplified electromigration bring analytes upstream until the convection balances the 
electromigration (Fig 1.2c), resulting in the enrichment of negatively charge analytes at the 





Fig 1.2 Mechanism of ICP-based analyte enrichment.   
(a) EOF of the 1st kind dominates at positions away from the nanostructures. (b) The amplified 
electromigration and the back flow of the vortical flow overcome the EOF of the 1st kind in the 
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depletion zone. (c) Analytes accumulate at the position where electromigration and convections 
balance.  
 
The overlap of electrical double layers (EDLs) was previously believed to be the cause of 
this ion-selectivity in nanochannels, but recent research showed that the ratio of surface conduction 
to bulk conduction is the key for this phenomenon [63]. Most of the silica-based preconcentrators 
[16,60,64–67] including our devices in Chapter 4 have nanochannels at the sizes of ~30-40 nm, 
but the thickness of EDL is usually < 3 nm, depending on the specific buffer solution they used. 
These devices can still induce ICP-based preconcentration with non-overlapped EDLs, because 
surface conduction (the ion conduction in EDLs) causes additional cations (counter-ions)  to 
transport through the nanochannels. This additional cation conduction through the EDL is usually 
overwhelmed by bulk conduction unless the channel size is comparable to the EDL thickness. This 
additional cation conduction initiates a weak ICP and slightly lowers the ion concentration at the 
anodic side of the nanochannel. The lower ion concentration increases the perm-selectivity of 
nanochannels due to the local thicker EDL, which in turn initiates a positive-feedback toward the 
faster formation of full ICP. This positive-feedback mechanism enables the use of ICP-based 
preconcentration even at moderate or high (~100mM) ion concentrations. 
 
1.3 Important factors in ICP-based preconcentration 
 
1.3.1 Dukhin number and nanochannel sizes 
There are many factors that may vary the ICP-based enrichment, including channel sizes, 
ionic strength, applied voltages, surface charge density, pH values of the sample solutions etc. As 
we discussed above, surface conduction (EDL conduction) in nanochannels (membranes) is the 
key factor for ion-selectivity. The surface conduction is the ion current through EDL, which is 
induced by the electric field across the channels. The ion current through EDL is mainly composed 
by the transport of counter-ions since counter-ions outnumber the co-ions in EDLs, which is the 
cause of the ion-selectivity. The ion-selectivity can be quantified by the Dukhin number, which is 
the ratio of the surface conductivity to the bulk conductivity [63]. The Dukhin number indicates 
the dominant mechanism of conduction and the ion-selectivity of the nanochannels.  
 
To induce ICP, the size of the nanochannel has to be at the same scale as the characteristic 
thickness of the EDLs (Debye length). As the channel size decreases down to tens of nanometers, 
the bulk conduction decreases dramatically and therefore the Dukhin number as well as the ion-
selectivity increases accordingly. For example, most of the ICP-based preconcentrators on 
silicon/silica substrates use ~40 nm nanochannels, while their systems have Debye lengths ~ 3 nm 
[16,60,64–67]. Although the EDLs are not overlapped in these devices, the bulk conduction has 
been decreased to the extent that the surface conduction cannot be overwhelmed by the bulk 
conduction anymore, resulting in the ion-selectivity in these nanochannels. With larger sizes, the 
nanochannels cannot provide enough ion-selectivity and in turn cannot induce ICP development.  
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1.3.2 pH value 
In addition, the pH value of the sample solution also plays an important role in ICP-
enhanced immunoassays. First, the pH value determines the charge density on the surfaces of 
micro-/nanochannels. For example, in a silica-based device, a higher pH induces more 
deprotonated silanol groups and therefore results in higher charge density on the silica surfaces. 
The surface conduction and Dukhin number increases as the charge density increases, which in 
turn enhances the ICP development. Second, the pH value not only affects the surface charge 
density on channel sidewalls but also changes the surface charges on analyte molecules. Based on 
the concept of ICP, only charged molecules can be trapped at the boundary of the depletion zone. 
If the pH value of the sample solution is the same as the isoelectric point (pI) of the target molecules, 
then most of the molecules are neutral. Thus, analytes cannot be enriched by electrokinetic force, 
when the pH value of the solution equals the pI value of analytes. The pH value also determines 
the electrical mobility of analytes by changing the surface charge on molecules. Since the analyte 
accumulation depends on the counteracting effects of the electromigration and the convection (the 
bulk flow induced by the EOFs of the 1st kind and the vortical flow caused by the EOFs of the 2nd 
kind) at the interface of the depletion zone, different molecules can be trapped at different locations 
based on their electrical mobilities [68]. Thus, by changing the pH value of the solution, 
researchers can determine which analyte can be enriched and where the analyte can be trapped. 
Third, the pH value also affects the efficiency of the immunoassay integrated with the ICP-based 
preconcentration. By adjusting the pH value far away from the pI value of the targets, researchers 
can achieve more efficient trapping of the target molecules. However, the pH value also 
significantly affects the antibody-antigen binding affinity. For example, the equilibrium constant 
of the same antibody-antigen pair is 100-fold higher at neutral pH than at pH 5.0 or 9.5 [69]. 
Therefore, extreme pH values should be avoided for ICP-enhanced immunoassays using 
antibodies.  
 
1.3.3 Different materials  
Besides the pH values of sample solutions, surface charge density also varies among 
different substrate materials. Thus, silica surfaces are usually preferred rather than silicon surfaces 
for ICP development [16,60,64–67], since silica surfaces have more silanol groups available and 
in turn have higher charge density than silicon surfaces. The higher charge density of the surface 
increases the surface conduction in EDLs, which is helpful for ICP development. Nafion 
membrane is also commonly used for ICP-based preconcentration due to its high surface charge 
density [68,70–78].  
 
1.3.4 Ionic strength 
Furthermore, ionic strength is another deterministic factor for ICP-based preconcentration. 
Lower ionic strength leads to higher zeta potential on the substrate surfaces, which in turn results 
in a faster electroosmotic flow. Electroosmosis is the leading cause of the bulk flow, and the bulk 
flow brings all the analytes toward the enrichment zone. Thus, the change in background ionic 
strength affects the flux of analyte molecules entering the enrichment zone, and as a result, 
determines the speed of the enrichment. More importantly, the lower ionic strength of the sample 
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solution induces thicker EDLs, which enhances the ion-selectivity of nanochannels. Thus, ICP can 
be initiated and developed faster in the solution with lower ionic strength. The efficiency of analyte 
trapping is higher at lower buffer concentrations with fewer molecules leaking through the 
nanochannels (or membranes).  
 
However, lower ionic strength is not always better for the ICP-based preconcentration. 
Although the lower ionic strength can accelerate the ICP-based analyte accumulation, the final 
achievable concentration factor may decrease if the background buffer concentration is too low. 
The concentration factor is defined as the ratio of the final peak analyte concentration to the initial 
analyte concentration. At high buffer concentrations, the thinner EDLs in nanochannels lead to a 
compromised ion depletion effect due to lower surface conductivity and weaker cation-selectivity. 
Thus, the analytes cannot be trapped efficiently by the compromised depletion zone, resulting in 
analytes leaking through the depletion zone. In this ‘leaking’ regime, lowering the buffer 
concentration can improve the ICP development and therefore enhance the analyte trapping 
efficiency, entering ‘non-leaking’ regime and achieving higher concentration factors [62].  
 
In the ‘non-leaking’ regime, the ICP can be fully developed, and the depletion zone can 
perfectly trap the analytes. After the system enters the ‘non-leaking’ regime, decreasing the buffer 
concentration lowers the peak analyte concentration and the concentration factor. This is because 
when the analytes are perfectly trapped and highly concentrated, the negatively charged analytes 
replace background anions, becoming one of the leading charge carriers in the enrichment zone. 
When the background anion concentrations decrease down to zero to maintain electroneutrality, 
the cations are neutralized solely by negatively charged analytes, and the analyte concentration 
can no longer be concentrated further. Thus, in the ‘non-leaking’ regime, the background buffer 
concentration determines the final analyte concentration, and therefore, lowering the buffer 
concentration in this regime decreases the concentration factor [62]. This effect is not problematic 
for the purpose of immunoassays since most antibody pairs can detect antigens easily at 
micromolar concentrations, while most of the preconcentrators use background buffers at 
millimolar levels [61], which are at least three orders of magnitude higher than the concentration 
we need for biomolecule detections.  
 
1.4 Current fabrication methods to induce ICP-based 
preconcentration 
 
ICP development requires ion-selective nanochannels or nanopores (in perm-selective 
membranes) connecting to microscale channels. There are many methods reported for the 
fabrication of these nanofluidic features. These fabrication techniques can be categorized by 
different materials. The earlier fabrications of these nanofluidic devices used expensive 
nanofabrication techniques on silicon/silica substrates. These fabrication techniques are costly, but 
they are usually CMOS compatible and do not require non-conventional fabrication tools. Recently, 
multiple cheaper prototyping approaches have been developed using perm-selective membranes 
such as Nafion. Nafion patterning is one of the most widely used fabrication strategies for ICP-
based enrichment due to its cheaper and faster prototype process with no requirement for clean-
room settings. Also, there are other non-lithographic methods in literature such as self-assembled 
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colloidal nano-beads [79,80], elastomeric microvalves [81], PDMS wrinkling [82], and 
nanojunction gap breakdown with high voltage [83]. In section 1.4, we present the current 
fabrication strategies for ICP-based preconcentrators.  
 
1.4.1 Silicon/silica based preconcentrator 
ICP-based preconcentration was first reported with silicon/silica nanochannels [60][67]. 
These devices were fabricated using conventional photolithography tools. The 5 µm – 20 µm wide 
nanochannels were patterned on the silicon substrate first and etched with reactive ion etching 
(RIE) for the depth of 40 nm. After etching the nanochannels, the microchannels were then 
patterned and etched with a similar process, except that a longer RIE process was used for deeper 
channels in microscale. Subsequently, the through-hole reservoirs were achieved by KOH etching 
or manual grinding. After fabricating all features on the silicon substrates, a layer of thermal oxide 
was grown on the device for better electrical insulation. After oxidation, the devices were sealed 
with a silica or glass wafer by anodic bonding, or the devices could be sealed using 
polysilsesquioxane (PSQ) as an adhesive layer (see details in Chapter 3).  
 
In these devices, the nanofluidic channels are only 40 nm deep, and the Debye length is no 
longer negligible (at buffer concentrations ~10 mM). For the negatively charged silica surfaces, 
these nanochannels can be cation-selective, transferring more cations (counter-ions) than anions 
(co-ions). This cation-selectivity results in the development of ICP and analyte preconcentration. 
Most of these silicon/silica-based preconcentrators use horizontal nanochannels as we described 
above [16,60,64–67]. These nanochannels cannot provide enough fluidic flow through the 
nanofluidic channels. Therefore, all of these preconcentrators have their nanochannels 
perpendicular to the main microchannels so that the main flow does not go through these 
nanochannels, which leads to more complicated structures and more difficulties in multiplexing.  
 
Compared to horizontal nanochannels, hundreds of vertical nanochannels can provide 
more volumetric flow through the nanochannels to enable sample loading and washing steps in 
immunoassays without the perpendicularity between nanochannels and microchannels. In Chapter 
4 of this dissertation, we report a new fabrication process for a nanostructure with hundreds of 
vertical nanochannels (nanogaps). In brief, the vertical nanochannels were etched with RIE and 
then shrunk from 250 nm to 30 nm with oxide deposition. These vertical nanochannels concentrate 
analytes by ICP development and collect microbeads via size filtering for bead-based 
immunoassays. Bead-based immunoassays have been successfully performed in front of these 
vertical nanochannels and the sensitivity is improved by two orders of magnitude (details in 
Chapter 4).  
 
1.4.2 PDMS based preconcentrator using horizontal Nafion membranes 
Instead of fabricating silicon/silica-based nanochannels, which requires clean rooms and 
advanced photolithography tools, researchers can pattern a thin layer of perm-selective membrane 
on a glass slide and then bond a layer of PDMS with microchannels on top of that membrane to 
form an ion-selective junction [68,70–78]. For example, Nafion is one of the most commonly used 
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ion-selective membranes, with high surface charge density due to its strongly negatively charged 
sulfonic groups.  
 
There are generally two ways to pattern Nafion membranes - micro-flow patterning and 
micro-stamping [61][78]. In the micro-flow patterning method, a PDMS layer with microchannels 
defining the membrane shapes is reversibly bonded to the glass substrate followed by the loading 
of Nafion perfluorinated resin. Then, the resin is completely removed by applying negative 
pressure on one end of the channel. After curing at 95 oC, the PDMS layer is removed, leaving the 
Nafion membrane on the glass substrate. Finally, the PDMS chip with preconcentrator structures 
is bonded on the Nafion patterned glass substrate via conventional plasma bonding. In this method, 
the thickness of the Nafion membrane can be tuned by varying the concentration of the Nafion 
resin and the incubation duration of resin in the microchannel. Alternatively, the Nafion membrane 
can be patterned on the glass substrate by micro-stamping. In this method, a block of PDMS with 
stamping patterns is dipped into Nafion perfluorinated resin, and then the Nafion resin is stamped 
onto the glass substrate. After curing the Nafion resin, the PDMS chip is bonded on top of the 
Nafion membrane with the same process as the micro-flow patterning method.   
 
1.4.3 PDMS based preconcentrator using vertical Nafion membranes 
In addition to horizontal Nafion membranes, another technique called ‘self-sealed’ junction 
method is also useful to build PDMS concentration devices with vertical Nafion membranes [84]. 
This method utilizes the flexibility and softness of PDMS to insert Nafion membranes into the 
devices without additional photolithography processes. The PDMS chip with preconcentration 
structure is cut with a knife at the location where the nanofluidic junction is supposed to be. Then, 
the gap is opened by bending, and the Nafion resin is infiltrated into the incision. After Nafion 
resin infiltration, the PDMS is released to close the gap, and excessive Nafion resin on the surface 
is removed manually. The Nafion resin is trapped and cured in the incision, followed by plasma 
bonding of the PDMS chip onto a glass substrate. In this technique, the Nafion membrane is 
vertically inserted into the PDMS layer with a high aspect ratio, which enables a high throughput 
preconcentration device with large channels (1000 µm width x 100 µm depth).  
 
1.4.4 Other methods to induce ICP based preconcentration 
Instead of using silicon/silica nanochannels or ion-selective membranes, one can also use 
self-assembled silica nano-beads to achieve ion-selective nanofluidic junctions [79,80]. In this 
technique, polyelectrolytes are deposited layer by layer on top of 300 nm colloidal silica beads, 
and these silica beads are then loaded into the bead delivery channels. After air drying for three 
hours, colloidal silica beads form a cation-selective membrane by self-assembly with an average 
pore size ~15% of the silica bead diameter. The pore size of the resulting nanoporous membrane 
can be further tuned by ionic strength [85], the pH value of the solutions [85,86], and temperature 
[87].  With this technique, Syed et al. preconcentrated DNA up to 1700 fold in ~10 min [80].  
 
Besides colloidal beads, there are some other techniques to fabricate ion-selective 
nanofluidic junctions with PDMS only. For example, an elastomeric microvalve can be used to 
create a nanofluidic junction within the sample channel to induce ICP [81]. In this technique, there 
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is a control channel on top of the sample channel. Applying pressure in the control channel can 
close the valve, forming nano-space underneath the microvalve in the sample channel. The nano-
space heights vary between ~55 nm and ~7 nm depending on the pressure applied in the control 
channel. The advantage of this technique is that the concentrated analytes can be transported 
downstream by opening the valve, in case that concentrated sample collection is desired.  
 
In addition to microvalves, nanochannels can be formed via a PDMS wrinkling process. 
After oxygen plasma treatment, a thin stiff film can be formed on a stretched PDMS surface [82]. 
This stiff film is mainly composed of SiOx, the density of which is approximately 50% of the 
density of silica. After slowly releasing the PDMS layer, a sinusoidal wrinkled surface can be 
formed on top of the PDMS layer [82]. The amplitude and period of the wrinkled surface vary 
between 50-600 nm and 100-3500 nm, respectively, depending on the magnitude of the strain and 
the exposure time to the plasma. To localize the wrinkled pattern in the nano-junction area between 
microchannels, the researchers usually cover the PDMS layer with a mask during oxygen plasma 
except for the nano-junction areas. Besides the oxygen plasma treatment, focused ion beam [88] 
and ultraviolet/ozone [89] can also be used to create such wrinkled nanochannels.  
 
Another non-photolithographic technique to create nanofluidic junctions is to use high 
voltage to break down the junction gap between two PDMS microchannels [83]. In this technique, 
a PDMS layer with two adjacent microchannels is irreversibly bonded onto a glass slide after 
standard oxygen plasma treatment. After filling both of the microchannels with 10-2 M phosphate 
buffer, a high voltage (>1000V) is then applied between two microchannels, forming nanogaps by 
electrical breakdown. This technique is straightforward, but the limited ion-selectivity of the nano-
junctions and the non-reproducible bonding strength between silica and PDMS constrain the 
efficiency of analyte preconcentration.  
 
Furthermore, there are multiple other materials and techniques to induce ICP-based analyte 
enrichment. Chun et al. developed an ICP-based preconcentrator using a poly-AMPS (2-
acrylamido-2- methyl-1-propanesulfonic acid) membrane between two microchannels [90]. Poly-
AMPS is a cation-selective polymer membrane, and the sulfonic groups keep AMPS negatively 
charged over a wide pH range. Song et al. reported an ICP preconcentration device with a 50 µm 
thick nanoporous Zwitterionic polymer membrane between two microchannels [91]. The 
Zwitterionic polymer membrane was fabricated inside the junction of two microchannels using 
laser-patterning. In the laser-patterning process, a monomer solution was loaded in the 
microchannels followed by the excitation with a 355 nm laser beam. The laser exposure triggered 
the polymerization and resulted in a membrane formation in the junction between two 
microchannels. In addition, Dhopeshwarkar et al. and Hlushkou et al. reported ICP development 
and biomolecule enrichment using ion-selective hydrogel micro-plugs [92,93]. Furthermore, 
Nafion can also be integrated onto paper-based devices (µPADs) in order to enhance the sensitivity 
of paper-based immunoassays. By depositing Nafion in the center of the wax-printed µPADs, 
Yang et al. reported ~20-fold enrichment of fluorescein-labeled bovine serum albumin (FITC-
BSA) with a convergent-channel design in 130 s [94] and Yeh et al. demonstrated an 835-fold 
concentration of FITC-BSA with shallow paper-based channels [95].  
 
1.5 Dissertation outline 
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In this thesis, we present two major topics - protein patterning with germanium as a 
sacrificial layer and ICP-enhanced immunoassays.  
 
In Chapter 2, we demonstrate the use of germanium (Ge) films as water-soluble features 
that allow the patterning of proteins onto surfaces with commonly used organic solvents. As 
researchers miniaturize biosensors and microfluidic devices down to submicron scales, high-
resolution biomolecule conjugation compatible with these processes is highly desirable. The 
presented technique is scalable to high volume manufacturing and is compatible with nano- and 
microfabrication processes, including standard lithography. We show that 50 nm thick Ge layers 
can be completely removed in 10 min without residues remaining on the surface. More importantly, 
nanoscale resolution and misalignment can be achieved with conventional photolithography 
equipment. Also, the process can be used to functionalize sidewalls, a capability of recent interest 
for cell-cell adhesion studies. 
 
In Chapter 3, we discuss the development of ICP-based preconcentration devices on silica 
and silicon substrates. This chapter explains why we started with a single-nanochannel 
preconcentrator on silica substrates and then switched to a multi-nanochannel design with deeper 
etching. We also report two nanofabrication strategies in this chapter to enhance the accumulation 
of protein molecules via 1) an increase in the number of nanochannels per microchannel and 2) an 
increase in the depth of nanochannels. Both of these two strategies provide a higher volumetric 
flow rate and protein accumulation rate.  Increasing the depth of nanochannels leads to the switch 
from silica substrates to silicon substrates, using different etching techniques. This chapter also 
includes the DRIE recipe for high-aspect-ratio nanochannels. Besides the fabrication challenges, 
multiple attempts at surface protein immobilization are also reported in this chapter. However, due 
to the instability of antibodies in the drying process, bead-based immunoassays are used in the 
next chapter. 
 
Chapter 4 presents a scalable method for fabricating vertical nanochannels (6.5 µm deep) 
employing ion concentration polarization (ICP) enrichment for fast analyte detection. Compared 
to horizontal nanochannels, massively paralleled vertical nanochannels not only provide 
comparable electrokinetic functions but also significantly reduce effective fluid resistance in each 
microfluidic channel, which enables microbead loading for sensing purposes.  These nanochannels 
filter microbeads by size and preconcentrate analytes at the anodic side of the test area via 
electrokinetic entrapment. The device is capable of enriching protein molecules by >1000 fold in 
10 min. We demonstrate fast detection of IL6 down to 7.4 pg/ml with only a 10 min enrichment 
period followed by a 5 min incubation, which is a 162-fold enhancement in sensitivity compared 
to that without enrichment. Our results demonstrate the possibility of using silicon/silica-based 
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Chapter 2 : Germanium as a scalable 
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2.1 Abstract  
We demonstrate the use of germanium (Ge) films as water-soluble features that allow the 
patterning of proteins onto surfaces with commonly used organic solvents. This technique is 
scalable for manufacturing and is compatible with nano- and microfabrication processes, including 
standard lithography. We use Ge as a sacrificial layer to mask and protect areas of the substrate 
during surface functionalization. Since Ge dissolves in 0.35% hydrogen peroxide (H2O2) in water 
but not in organic solvents, Ge can be removed after patterning without significantly affecting 
protein activities. In this chapter, we present examples of protein patterning with two different 
techniques. We show that 50 nm thick Ge layers can be completely removed in 10 min without 
residues and, importantly, nanoscale resolution and misalignment can be achieved with 
conventional photolithography equipment. Both biotin and streptavidin maintain ~80% and >50% 
activity after 10 min and 360 min incubation in 0.35% H2O2, respectively. Lastly, the process can 
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As researchers miniaturize biosensors and microfluidic devices down to submicron 
scales[96–98], high-resolution biomolecule conjugation compatible with these processes has 
become desirable. Several protein patterning techniques have been demonstrated, including 
gasket-based patterning[99,100], microcontact printing (µCP)[100–104], and dip pen lithography 
(DPL)[105–107]. Gasket-based patterning is the easiest and arguably most popular protein 
patterning approach in academic work. In this approach, removable polymer gaskets, usually made 
of polydimethylsiloxane (PDMS), are used as a mask on the conjugation surface to localize surface 
functionalization reagents. Since alignment is usually performed manually, it is difficult to 
precisely align the polymer gaskets with existing surface structures. This method is suitable for 
low resolution and low throughput research projects, but is difficult to scale up. DPL and µCP are 
both based on the contact between small probe tips with surface chemistry reagents and a substrate 
surface. µCP uses PDMS stamps with micron[101,104] or, more recently, submicron features[103] 
to pattern functionalization reagents onto a substrate. This method exhibits higher resolution and 
throughput than that of gasket-based methods, but the alignment between desired protein patterns 
and existing features is limited by the alignment tool. DPL involves using an atomic force 
microscopy (AFM) tip to trace out the functionalization patterns and can achieve nanoscale 
resolution with submicron alignment, but usually requires custom AFM systems and is thus 
difficult to scale up for bulk manufacturing.  
 
To achieve high resolution, precise alignment and bulk manufacturability, engineers have 
long turned to photolithography techniques to pattern surface moieties. For example, 
lithographically patterned gold films can be functionalized with thiol groups to pattern proteins 
onto gold surfaces selectively[108–110]. However, gold thin films may have strong interference 
with fluorescent signals, so this process may not be suitable for some cases requiring a fluorescent 
readout. Another common technique involves depositing a sacrificial layer, such as common 
photoresists, to occlude a region of the surface where conjugation is unwanted, and subsequently 
dissolve the sacrificial layer with a biocompatible solvent[98,111,112]. However, photoresists can 
be problematic for surface chemistries that require organic solvents, since photoresists dissolve 
quickly in most of the commonly used organic solvents (e.g. ethanol, acetone, isopropyl alcohol 
(IPA) and dimethyl sulfoxide (DMSO)). For example, silane is commonly used for silica surface 
functionalization, but due to the hydrolysis of silane groups in aqueous solution, an organic solvent 
like ethanol or DMSO is preferred for silane dissolution in order to maintain the activity of silane 
groups. A sacrificial layer which will dissolve in a biocompatible solution but not in commonly 
used organic solvents would enable precise surface conjugation across a wider range of surface 
chemistries. While there are alternatives to photoresist such as using a dissolvable metal as a 
sacrificial layer in protein lift off[113], the dissolution rates of these metals are low at neutral pH, 
they are difficult to deposit, and some are flammable. 
 
 Here, we demonstrate a simple, inexpensive and manufacturable protein patterning 
technique with submicron resolution and only nanoscale misalignment using germanium (Ge), a 
semiconductor material, as a sacrificial layer for a lift-off process. This method is suitable for 
creating patterns of a target material on a surface using a sacrificial material. Ge has been studied 
for decades in the field of microelectromechanical systems (MEMS) and has been used as a 
sacrificial layer due to its solubility in aqueous solutions[114,115]. Ge dissolves slowly in aqueous 
solution, but is not affected by most organic solutions[116]. Germanium is first oxidized into 
germanium dioxide by oxidizing agents (e.g. dissolved oxygen molecules or aqueous hydrogen 
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peroxide (H2O2)). H2O2 accelerates the oxidation of Ge since it is a much stronger oxidizing agent 
than oxygen molecules. The spontaneous dissolution of germanium dioxide in water (containing 
some oxidizer) exposes more Ge for further oxidation until complete dissolution of the Ge 
sacrificial layer occurs[114,115].  
 
In brief, our process is as follows: A thin layer of germanium is first patterned. The entire 
surface (containing germanium and non-germanium coated surfaces) is then functionalized and 
the germanium is then dissolved away, leaving biomolecules only on the surfaces that originally 
were uncoated by germanium. The whole process is scalable and easy to apply in any 
microfabrication lab, as it relies on standard thin film techniques. In addition, germanium and its 
dissolution products are biocompatible, which enables the use of this technique for both in vitro 
and in vivo devices[117].  
 
 In this chapter, we report protein patterning results from two different Ge deposition 
processes, E-beam evaporation and low temperature chemical vapor deposition (LPCVD). Since 
E-beam evaporation is more directional (more material deposited on horizontal surface than on 
vertical sidewalls) and LPCVD is more conformal (same film thickness on both vertical and 
horizontal surfaces), LPCVD protects vertical walls from biomolecule attachment while E-beam 
evaporation enables sidewall functionalization, which is a topic of recent interest[118]. Both biotin 
and streptavidin surface activity were characterized with various incubation periods in 0.35% 
H2O2. To our knowledge, this study is the first demonstration of protein nanoarray fabrication with 
Ge as a sacrificial layer.  
 
2.3 Experimental Methods 
2.3.1 Fabrication  
Substrate features were first patterned onto p-type silicon wafers by conventional 
photolithography techniques. Deep ultraviolet (DUV) photoresist (Dow UV210-0.6) was spun at 
7000 rpm for 420 nm final thickness, exposed in ASML 5500/300, developed in MF26A for 1 min 
and hard baked for 2 h at 120oC (all DUV photoresists were patterned with these conditions unless 
otherwise indicated). Wafers were then etched in a Lam TCP 9400SE Etcher to provide 120 nm-
deep alignment markers, which enabled alignment of protein patterns with substrate features in 
subsequent germanium patterning. In this chapter, we etched 500 nm deep square wells into the 
substrate in a Lam Etcher system to demonstrate alignment accuracy and sidewall 
functionalization.  After well etch, we deposited a layer of high-temperature oxide (HTO) in a 
TYTAN Diffusion Furnace System at 900oC. HTO was not necessary for our protein patterning 
technique with a Ge mask, but provided a blank surface with binding sites for silane chemistry. If 
other surface chemistries are used, the HTO step can be skipped and the Ge process applied after 
substrate fabrication.  
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There are two Ge fabrication methods presented in this chapter (Fig 2.1). In method 1, we 
used an E-beam evaporation and lift-off process to pattern Ge. DUV photoresist (Dow UV210-






In this work, we patterned micron scale squares inside the previously etched square wells 




Fig 2.1 Fabrication process overview.  
Left) 50 nm Ge layer is patterned with E-beam evaporation and a lift-off process. Vertical 
sidewalls are functionalized along with horizontal openings. Right) 50 nm Ge layer is patterned 
with LPCVD and etching. Vertical sidewalls are completely covered and not exposed to 
functionalization solution. After Ge patterning and surface chemistry, Ge layer is dissolved in 
0.35% H2O2 and the chip is ready to use.  
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a CHA E-beam Evaporator at 10-6 Torr base pressure. The surface conjugation areas were then 
exposed by stripping photoresist in 1-methyl-2-pyrrolidone (NMP). In method 2, we deposited Ge 
first with LPCVD and then etched away Ge in surface functionalization areas. 50 nm thick 
germanium was deposited in a TYTAN Diffusion Furnace System at 340oC after depositing a layer 
of 2 nm amorphous silicon as an adhesive layer between HTO and Ge. Then, 420 nm DUV 
photoresist was patterned over the germanium. Germanium exposed through the photoresist was 
completely etched away in a Lam TCP 9400SE Etcher to open windows for protein patterning in 
the next step.  The plasma etching of germanium had high selectivity against HTO so that HTO 
also worked as a stop layer during germanium etching. After Ge patterning with either method, we 
brought the substrates in contact with 25 mg/ml silane-PEG-biotin (Nanocs, New York, NY) in 
ethanol or dimethyl sulfoxide (DMSO) and incubated for 30 min at room temperature. After 
washing away excess silane solution, wafer substrates were immersed in deionized (DI) water with 
0.35% hydrogen peroxide to strip Ge. After the dissolution of germanium, wafers with biotin 
patterns were washed in DI water and blown dry with nitrogen, followed by storage in a 4oC fridge 
for future use.  
 
2.3.2 Ge dissolution 
Germanium dissolution rate as a function of H2O2 concentration, temperature and pH had 
been well characterized in literature[119]. For the first Germanium dissolution test in Fig 2.2, 
germanium films of 2 nm thickness were E-beam evaporated (as per Fabrication) on silica chips. 
Kapton tape was used to cover some chip area (leaving the center exposed), in order to provide 
enough contrast between Ge and non-Ge areas. Four circles were drilled around Ge deposited area, 
so that we could identify the Ge area even after complete dissolution. Ge deposited silica chips 
were then immersed into pure DI water, DI water with 0.35%w/v hydrogen peroxide, NMP, IPA, 
acetone, DMSO and ethanol for 10 min, 30 min, and overnight to test the dissolution rate in 
different solutions.  
 
For the dissolution test in Fig 2.3, we fabricated as following. Before surface conjugation 
with silane chemistry, dissolution of Ge was tested in 0.35% H2O2 and surfaces were imaged with 
a Gemini Scanning Electron Microscope (SEM) before and after dissolution. Substrates were first 
patterned with 25 µm by 25 µm square wells that were etched 500 nm deep, followed by 100 nm 
HTO deposition. A layer of 50nm Ge was deposited in an LPCVD furnace and 3 µm by 3 µm 
squares were etched inside the square wells. The etching recipe had a 20 s overetch after the 50nm 
Ge etch to ensure all Ge and amorphous Si on top of the HTO was etched away. Substrates were 
then imaged in SEM to identify the Ge surface versus oxide surface. After immersion in 0.35% 
H2O2 for either 10 min or overnight at room temperature, substrate surfaces were imaged by SEM 
again to characterize the surface after Ge dissolution. It was very easy to distinguish oxide from 
Ge in SEM, since the oxide surface was smoother and brighter than the Ge surface which had 
micron-size grains.  
 
2.3.3 Labeling patterned biotin with fluorescent streptavidin 
Prior to functionalization, 25 µm by 25 µm and 42 µm by 42 µm square wells were etched 
500 nm deep into the silicon wafer, followed by 100 nm HTO deposition. All samples were 
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separated into two groups. Group 1 and 2 were fabricated and functionalized using Method 1 and 
2, respectively (Fig 2.1). 3 µm x 3 µm and 5 µm x 5 µm squares patterned inside 25 µm x 25 µm 
and 42 µm x 42 µm square wells (16 squares per well) were biotinylated using silane-PEG cross 
linker (see Fabrication). Wafers were then incubated with 1% bovine serum albumin (BSA) 
blocking solution for 1 hour at room temperature to prevent nonspecific binding. Streptavidin 
conjugated with Alexa-Fluor 647 (Strep-647) was used to fluorescently label the biotinylated 
surface by incubating 10 µg/ml Strep-647 in 1X PBS with substrate surfaces for 30min at room 
temperature, after which Ge was removed by 10 min-immersion in 0.35% H2O2 with mild stirring. 
Since Ge is dissolved after Strep-647 labelling, it was not strictly necessary to incubate in blocking 
solution; the step was carried out to be certain that Strep-647 bound to biotin specifically (as 
streptavidin is known to bind nonspecifically to surfaces). We did not find significant signal 
decrease due to oxidation in H2O2, so all Strep-647 labeling was done before Ge dissolution (with 
the exception of the experiment to test biotin activity in H2O2). Fluorescent images were taken 
using a Nikon Eclipse Ti fluorescent microscope after washing and blowing dry.  
 
2.3.4 Protein Nanopatterning 
The resolution of proteins patterned with Ge hard masks was limited by the 
photolithography process and exposure tools. In order to show that the limit was attributable to 
lithography limits, we pushed the resolution of our protein patterning down to 250 nm, the limit 
of our ASML model. For this experiment, 500 nm deep square wells were not etched before HTO 
deposition, since a 500nm height difference disrupted the uniformity (even distribution of 
photoresists) of DUV photoresist coating (420 nm thick) and affected submicron lithography. 
Thus, protein nanoarrays were fabricated on flat silicon wafers with 100 nm HTO and Method 2 
was used to pattern 50 nm Ge film with 1 µm x 1 µm, 500nm x 500nm, 300nm x 300nm and 
250nm x 250nm openings for conjugation. Biotinylation of nanoarrays was performed as per 
Fabrication. Strep-647 was then used as described above to label biotin molecules on the surface. 
Fluorescent images were taken with a Carl Zeiss Elyra SR.1 Super Resolution Microscope in order 
to resolve the 250 nm squares.  
 
2.3.5 Stability testing of streptavidin and biotin after incubation in diluted 
H2O2  
As the concentration of H2O2 used for Ge dissolution was very low, both biotin and 
streptavidin surface exhibited sufficient activity for the following experiments. Biotin-conjugated 
chips were fabricated as above. Biotin activity was demonstrated by incubating biotin conjugated 
chips in 0.35% H2O2 for various periods from 10 to 360 min at room temperature. For streptavidin-
activity tests, biotin conjugated chips were first incubated with 100ug/ml non-fluorescent 
streptavidin solution for overnight to get streptavidin surfaces. Streptavidin conjugated chips were 
immersed in 0.35% H2O2 for different incubation periods as per biotin groups. (Note, sufficient 
H2O2 solution and a sealed the container should be used for long incubations to prevent drying. If 
the H2O2 solution dries or too much water evaporates during incubation, neither biotin nor 
streptavidin survive).  After H2O2 incubation, biotin and streptavidin chips were blocked in 1% 
BSA for 1h at room temperature before brought in contact with Strep-647 and Atto-488 Biotin 
    18
(Biotin-488), respectively.  Fluorescent images were then taken with a Nikon Eclipse Ti 
fluorescent microscope after washing and blowing dry. 
2.4 Results & Discussion 
2.4.1 Germanium dissolves in diluted H2O2 rapidly but not in organic solvents 
 Germanium dissolves easily in aqueous solution but not organic solutions. As shown in 
Fig 2.2, brown areas indicated by black arrows are areas deposited with 2nm Ge, which 
dissolved completely in pure DI water and water with 0.35% w/v H2O2 in 30 min and 10 min 
respectively, but did not dissolve in any organic solvent after an overnight incubation at room 
temperature. Note, the Ge dissolution rate in 0.35% H2O2 is higher than 2nm per 10min. This 
experiment was to demonstrate the different dissolution rates of Ge in different solvent solutions 
qualitatively and to prove the feasibility of using Ge as a sacrificial layer for protein ‘lift-off’. 
 
Germanium dissolved completely in 0.35% H2O2 at room temperature. As shown in Fig 
2.3 A&B, each 25 µm x 25 µm well had sixteen 3 µm by 3 µm squares for functionalization. The 
exposed oxide area was smoother than the Ge layer, for which micro-scale grains were evident. 
After 10 min incubation in 0.35% H2O2, it was very clear that all Ge grains were completely 
removed and overnight incubation didn’t remove more material (Fig 2.3 C&D). Any residual Ge 
on the oxide surface would be very obvious in SEM. Thus, a 10min incubation in 0.35% H2O2 was 
sufficient to remove a 50nm Ge sacrificial layer. After Ge dissolution, 3 µm by 3 µm squares were 
still visible under SEM (Fig 2.3 C&D). This arose because the additional over-etch step in the Ge 
etching process etched away the 2 nm Si layer in those 3 µm by 3 µm conjugation regions, while 
the 2 nm Si layer elsewhere did not dissolve in H2O2 during Ge dissolution. 
 
As Strep-647 was dissolved in 1X PBS, the germanium layer oxidized and dissolved slowly 
during the 30min labeling process. The Ge dissolution rate in 0.35% H2O2 was accelerated if done 
after a 30min incubation in PBS. Importantly, a 30min incubation in PBS was insufficient to 
dissolve a 50 nm Ge layer. The germanium did not exhibit appreciable etching until 0.35% H2O2 
was added. This is evidenced by the low background intensity in Fig 2.4 as the intensity of the 
unconjugated area was not higher than that of a blank silicon wafer. On the other hand, the Ge 
surface integrity was less important since a biotin pattern was formed on chip surface during the 
silane chemistry step. Even if the Ge layer completely dissolves before streptavidin conjugation, 
streptavidin should only be immobilized on biotin surfaces. Thus, after biotin conjugation, 
Incubating chips in aqueous solution is not a problem. 
 





Fig 2.2 Germanium dissolution test.  
Silica chips with 2nm thick Ge layer were incubated in different solutions at room temperature 
for 10min, 30min and overnight. 
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2.4.2 Nanoscale patterning is achieved  
All biotinylated regions were successfully conjugated by fluorescent streptavidin. The 
results for both Ge patterning techniques, Method 1 & 2, are shown in Fig 2.4A&B, respectively. 
The fluorescent sidewalls in Fig 2.4A pointed out by red arrows indicate sidewall conjugation (in 
contrast to Fig 2.4B, which did not exhibit this). The intensity profiles along yellow dash lines in 
Fig 2.4 A&B are shown in Fig 2.4C&D respectively. Four major peaks represent 4 squares labeled 
with fluorescent streptavidin. There are two additional little peaks caused by sidewall conjugations 
on each side of the 4 major peaks, highlighted with red arrows in Fig 2.4C. These additional 
intensity peaks have much lower intensity than the major peaks, but still high enough to be 
 
 
Fig 2.3 Germanium dissolution.  
A) SEM image of 50 nm Ge films deposited by LPCVD before dissolution. Red arrow indicates 
the edge of a 25 µm by 25 µm square well, etched 500nm deep. B) Higher magnification of red 
box in A). C&D) SEM images of Ge layers after 10min C) and overnight D) incubation in 0.35% 
H2O2 at room temperature. Ge was completely dissolved in 10min with no residues left. Faint 
square outlines are due to the over-etch process in the Ge etching recipe and thus the adhesive 
amorphous Si layer between Ge and HTO is etched away.  
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distinguished from background, which are however not exhibited in Fig 2.4 D at all. This sidewall 
conjugation arose because of the non-conformal deposition of Ge evaporation:  evaporated 
ultrathin Ge films (e.g. 50 nm) covered only horizontal surfaces and left vertical sidewalls exposed 
for biotin conjugation. In contrast, LPCVD Ge films of the same thickness protect vertical 





Fig 2.4. Sidewall coverage depends on how conformal the deposition process is.  
Biotin microarrays were generated by either Method 1 (A) or Method 2 (B) illustrated in Fig 2.1 
Strep-647 was then used to label biotinylated surfaces. Sidewall conjugation is shown in A) 
pointed out by red arrows but not in B) due to the higher conformal deposition of LPCVD (B) vs. 
E-beam evaporation（A）. Intensity profiles along the yellow dash lines in A) and B), are shown 
in C) and D) respectively. Red arrow in C) correspond to the side wall intensity labeled by the 
red arrows in A). Any misalignment between conjugated regions and wells was too small 
(<100nm) to measure with our fluorescent microscopy.  
 
 
The use of modern deep ultraviolet (DUV) lithography enabled nanoscale protein 
patterning. As shown in Fig 2.5, all features ranging from 250 – 1000 nm were successfully 
resolved and conjugated with biotin. No nonspecific binding was evident. The feature rounding on 
smaller features was an artifact of submicron lithography. 
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2.4.3 Both biotin and streptavidin can maintain the activity after Ge 
dissolution 
 Both biotin and streptavidin could maintain activity after H2O2 incubation, as shown in Fig 
2.6. The activity was measured in terms of the number of fluorescent biotin or streptavidin 
molecules bound on streptavidin and biotin surfaces, respectively. Thus, the fluorescent intensity 
was proportional to the remaining activity of the surface molecule. With 10min 0.35% H2O2 
incubation, both biotin and streptavidin showed ~80% activity. Even after immersing in H2O2 for 
6h, biotin and streptavidin surface still had more than 50% activity remained. Longer incubation 
was not required for 50nm Ge dissolution; here the longer incubation periods were used to show 







Fig 2.5. Nanoscale protein patterning.  
Submicron squares were patterned with biotin and then labeled with strep-647. From left to right 
the squares have 1 µm, 500 nm, 300 nm and 250 nm sides, respectively; 250 nm is the resolution 
limit of the lithography tool. The inhomogeneity of fluorescent signal was most likely caused by 
the nature of super-resolution fluorescent imaging.  




In this work, we demonstrate the use of germanium sacrificial layers to achieve 
biomolecule patterning which is compatible with nano/microfabrication, scalable to high 
resolutions with precise alignment, and ultimately suitable for low cost and high volume 
manufacturing of biosensors. In addition, the method is applicable to a wide range of biomolecules 
and surface chemistries. It is of particular utility for surface conjugation chemistries which require 
organic solvents. Examples include the commonly used primary amine reactive chemical groups 
for protein labeling, such as N-hydroxysuccinimide ester (NHS), which hydrolyzes quickly in 
water and the conjugation of proteins onto silicon dioxide surfaces using silane-PEG-NHS. 
Because both functional groups hydrolyze in water, organic solvents are usually required and a 
germanium sacrificial layer would be of significant use.  
 
Two processes are reported in this chapter, each of which has specific advantages. Method 
1 uses evaporation and a lift-off process to pattern the Ge hard mask. This process avoids the high 
temperature deposition process of Ge and the aggressive etching process in Method 2. For LPCVD 
processing, all wafers must be cleaned in piranha and hydrogen fluoride (HF). This mandates that 
 
Fig 2.6. Biotin and streptavidin activity after H2O2 incubation.  
Microarrays were fabricated and conjugated with biotin as per Method 2. Streptavidin 
conjugated chips were obtained by incubating biotin conjugated chips with 100ug/ml non-
fluorescent streptavidin solution overnight. Both biotin and streptavidin conjugated chips were 
then incubated in 0.35% H2O2 for 10min, 30min, 60min, 3h and 6h at room temperature. After 
H2O2 incubation, all chips were blocked in 1%BSA. Biotin chips were then labeled with 10ug/ml 
Strep-647 while streptavidin chips were labeled with 1ug/ml Biotin-488. Intensity was 
normalized by using control group (0min) as 100% intensity.  
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there be no organic materials on substrate, which is often not the case for biosensor applications.  
Since Method 1 uses a lift off technique instead of etching, there is no need to have a stop layer 
(such as the HTO layer in our case) which is compatible with both the surface chemistry and the 
etching process. Thus, Method 1 is compatible with low-melting-point biomaterials underneath 
the Ge layer. We demonstrated nanoscale protein patterning only with Method 2. This is due to 
lift-off process in Method 1 requiring submicron pillars, which are much harder to resolve than 
submicron openings with positive photoresists. If an appropriate negative photoresist is available, 
Method 1 can also be used to resolve nano-features. Furthermore, sidewall functionalization can 
be achieved and controlled by using a non-conformal Ge deposition process (as in Method 1). On 
the other hand, the Ge film in Method 2 is much more uniform over the whole surface due to the 
conformal LPCVD process. It can successfully avoid protein immobilization on sidewalls, which 
may be preferred for some biosensor applications. 
 
This work employed biotin/streptavidin conjugation to demonstrate the germanium 
sacrificial proof of concept; both biotin and streptavidin surfaces were stable enough to maintain 
activity after 0.35% H2O2 incubation. We also used streptavidin as an example of the method’s 
use for protein patterning. Of note, streptavidin can be directly used as a cross linker to immobilize 
biomolecules. For example, after Ge dissolution, a protein can be immobilized on a biotin surface 
by conjugating a target protein with streptavidin first. Alternatively, streptavidin can be 
immobilized onto the surface first to capture biotin conjugated proteins onto the surface after Ge 
dissolution. We believe this method could have wide applicability across a variety of protein 
patterning applications. 
 
In this chapter, we successfully demonstrate a new method to conjugate biomolecules onto 
the surfaces in microfluidic channels, which is useful for microfluidic-based immunoassays. 
However, as we discussed in Chapter 1, we need to enrich target molecules to enhance the 
sensitivity and speed of immunoassays. Thus, we introduce an ICP-based preconcentrator in 
Chapter 3 as well as the process about how we developed from the single-nanochannel design on 
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Chapter 3：Silica-based ICP 





As we discussed in Chapter 1, the rate-limiting step for the detection of low-concentration 
analytes is the analyte transport to the biosensors. Thus, preconcentrating analytes to accelerate 
the analyte capturing without compromising the sensitivity becomes a heated topic.  
 
This chapter discusses the development of preconcentration devices on silica and silicon 
substrates. It explains how we started with single-nanochannel preconcentrator on silica substrates 
and then switched to multi-nanochannel design with deeper etching.  
 
Two different fabrication processes for nanochannels were demonstrated on silica 
substrates: e-beam lithography and deep-UV (DUV) lithography followed by oxide deposition. 
The latter was chosen for our project because it has higher throughput and results in a cleaner 
surface, which is better for sealing afterwards. After fabricating the preconcentrator with a single 
30 nm-wide nanochannel, we applied DC voltage across the preconcentrator to demonstrate the 
ion concentration polarization (ICP) based protein enrichment in front of that single nanochannel.  
 
One single vertical nanochannel is, however, unable to accumulate protein molecules fast 
enough for highly sensitive immunoassay due to the low volumetric flow rate in the microchannel. 
We also report two additional strategies in this chapter to enhance the accumulation of protein 
molecules, 1) increasing the number of nanochannels per microchannel and 2) increasing the depth 
of nanochannels. Both of these two strategies provide higher volumetric flow rate and carry more 
protein molecules to the enrichment zone in the same period of time.   
 
In order to increase the depth of nanochannels, we had to switch from silica substrates to 
silicon substrates, since DRIE for silica substrate was not available in our lab. Besides the 
fabrication challenges, we also attempted to immobilize proteins on the surfaces in front of the 
nanostructures. However, we found the drying process would deactivate antibodies, so we 
switched to bead-based immunoassays, as described in the next chapter.  
 
    26
3.2 Methods 
3.2.1 Design of single-nanochannel devices 
 The first single-nanochannel preconcentration device is fabricated on a silica substrate and 
has two main parallel channels connected by nanochannels (Fig 3.1a). The main channels are 3µm 
deep, 3 mm wide and around 1 cm long. As shown in Fig 3.1b, there are three microchannels 
connecting two main channels. Each microchannel is approximately 200 µm long, 30µm wide and 
300 nm deep and has a ~30nm wide,  ~1 µm long and 30 nm deep nanochannel in the middle (Fig 
3.1c). We chose to etch 300 nm deep for microchannels instead of using the same depth as the 
main channels because deep reactive ion etching (DRIE) was not available for silicon dioxide in 
our lab. The RIE tool requires a lot of parameter tuning or testing to provide a relatively higher 
aspect ratio. For example, in the e-beam lithography method, if we wanted to fabricate 3 µm deep 
channels, then the aspect ratio for nanochannel etching would be 100:1 (3 µm deep and 30nm 
wide).  
 
 Tubing and electrodes are connected through four reservoirs (two for each main channel). 
To apply DC voltages, the left main channel is connected to the anode, and the right channel is 
connected to the cathode during analyte preconcentration. The finished devices are sealed with 
another silica wafer (or coverslip, in the case of sealing a chip), with PSQ as the adhesive layer 
after oxygen plasma. For tubing purposes, a layer of PDMS with 4 through-holes is covalently 
bonded to the back side of the silica wafer with structures. The through-holes were used to form 
connections with rubber tubes and electrodes.  
 
3.2.2 Fabrication process of single nanochannel devices 
 We proposed two fabrication processes for nanochannels: 1) E-beam lithography(Fig 3.2a) 
and 2) Deep-UV (DUV) followed by oxide deposition(Fig 3.2b). Both of the nanochannel 
fabrication processes are shown in the schematic cross-section along the orange dashed line in Fig 
3.1b, while Fig 3.2 demonstrates the fabrication process for nanochannels only, and Fig 3.3 shows 
the complete fabrication process.  
 
 In the first method with E-beam lithography, the 300 nm deep microchannels connecting 
two main channels were patterned with DUV lithography with ASML 5500/300 (ASML, 
Veldhoven, Netherlands) followed by Reactive Ion Etching (RIE) in an inductively coupled 
plasma etcher (SPTS Technologies, Newport, UK). In this step, the left and right halves of the 
microchannels were 1 µm away from each other and not connected yet. Fig 3.2a only shows the 
cross-section of the nanochannel fabrication process, so these steps are not demonstrated in Fig 
3.2a.  
 
 Subsequently, the 30 nm nanochannel was fabricated with E-beam lithography on top of 
the microchannels to connect the left and right in the middle. For E-beam lithography, Poly(methyl 
methacrylate) (PMMA) was used as a high resolution resist, so 2% PMMA (495,000 g/mol) in 
anisole was first spin-coated on the silica wafer to form a 100 nm thick resist layer. Since the 
substrate was an insulator (silica), electrons could not be dispensed efficiently, which would 
    27
significantly lower the resolution of E-Beam lithography. Thus, a 20 nm thick layer of conductive 
polymer (ESPACER, Showa Denko, Japan) was spin-coated on top of the PMMA layer to avoid 
electron accumulation under the electron beam. Then the silica wafer (or diced silica chip) was 
exposed in Crestec (CABL-9510CC Electron Beam Lithography System) to direct-write the 30 




Fig 3.1 Overview of the single-channel nanofluidic device.  
(a) Schematic diagram of the entire device. There are two main channels connected by 
microchannels. Each main channel has 2 reservoirs, connecting to external fluidic tubing and 
contacting with electrodes. Each microchannel has 1 nanogap for analyte enrichment. (b) 
Close-up of the microchannels connecting two main channels. These microchannels are 100 µm 
long on each side of the nanogap, 30 µm wide and 300 nm deep. The nanogap in each 
microchannel is around 30 nm wide. (c) Close-up of the microchannel in (b). 
 
 
 After the E-beam writing in Crestec, the conductive polymer was washed away in water, 
and the PMMA was developed in the 1:3 MIBK: IPA developer. After development, the same RIE 
tool was used again to etch the nanochannels 300 nm deep. Finally, the residual PMMA was 
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removed using Remover PG (MicroChem, Westborough, MA), although this PMMA removal 
process was not very successful (see Results and Discussion). Note that the main channels 
fabrication is not included in this process, since the nanostructure was never successfully 







Fig 3.2 Two strategies for nanogap fabrication.  
(a) E-Beam lithography process. Since the device was based on a silica wafer, in order to 
dissipate the charge accumulated on the surface during E-beam Lithography, an additional 
conductive layer, E-SPACER 300Z (light green) was spin-coated on top of the positive resist, 
PMMA (orange). (b) Photolithography with oxide deposition process. Both processes are shown 
with the schematic cross-section at the orange dashed line in Fig 3.1b.  
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 Besides E-Beam lithography, we also proposed to fabricate nanochannels ~250 nm wide 
and ~300 nm deep with DUV and RIE on silica substrates, followed by an oxide deposition to 
shrink the nanochannel width from 250 nm down to ~30 nm (Fig 3.2b). The whole process of the 
chip is shown in Fig 3.3.  
 
 First, the microchannels with a ~250 nm nanochannel in the middle of each microchannel 
were fabricated on the silica wafer. A 50nm layer of Cr was deposited on the back side of the silica 
wafer because both the spin-coating tool and exposure tool required an opaque substrate. Then, a 
~60 nm thick layer of anti-reflective coating (AR3-600) was applied before a 420 nm thick layer 
of DUV photoresist (UV210-0.6, Dow Chemical, Midland, MI) was patterned on the front side of 
the silica wafer.  
 
 The microchannels and nanochannels were then etched ~300 nm deep with RIE in an 
inductively coupled plasma (ICP) etcher (SPTS Technologies, Newport, UK). The residual 
photoresists were removed using an oxygen plasma asher (Matrix Plasma Asher Model 106), 
followed by piranha cleaning at 120 oC for 10 min.  
 
 After fabricating the micro-/nanostructures, the main channels were fabricated with a 
similar process, except that a thicker layer of  DUV photoresist (~900 nm) was used. It was critical 
to pattern the ~300 nm deep microchannels before the main channels because the 3 µm tall side 
walls of the main channels would disturb the spin-coating process of ~420 nm photoresist for 
microchannels, while the ~900 nm thick photoresist could be coated fairly well on top of ~300 nm 
tall side walls without compromising the resolution.  
 
 After all features were etched, we deposited a layer of high-temperature oxide (HTO) at 
900oC with a TYTAN Diffusion Furnace System (Tystar, Garden Grove, CA) to reduce the 
nanochannel size from ~250nm to ~30nm. Four reservoirs were then ground manually with a 
dental drill to create access holes through the silica substrates after spin-coating a 10 µm thick 
layer of photoresist (SPR 220-7.0, Dow Chemical, Midland, MI) for surface protection. Since 
silica is relatively hard to etch (due to its slow etching rate), it takes hours to etch through-holes 
on silica surface. Thus, we chose to ground through-holes manually, which was quicker in the 
scale of prototyping (one or two wafers per batch).  
 
 After fabricating all the features on the silica wafer, we sealed the device with another silica 
wafer coated with ~100 nm thick polysilsesquioxane (PSQ, Gelest, Morrisville, PA) as shown in 
Fig 3.3. We adapted the similar process reported by Gu et al [120,121]. In short, the PSQ was 
diluted in xylene (2:3) and spin-coated on a plain silica wafer. For a better and more uniform 
coating, we cleaned the silica wafer with oxygen plasma in YES-G500 Plasma Cleaning System 
(Yield Engineering Systems, Livermore, CA) at 600W for 2 min. The PSQ-coated silica wafer was 
then baked in an oven overnight at 150 oC. The hard-baked silica wafer, along with the silica wafer 
with all the features, were oxygen plasma treated in YES-G500 at 100W for 1 min.  
 
 Oxygen plasma treatment would damage biomolecules’ activity. Thus, if biomolecules, 
such as biotin or antibodies, were immobilized in the microchannels, we only plasma-treated the 
PSQ silica wafer, while we kept the silica wafer with all the features and bioconjugations dry and 
clean. A weaker plasma was used in for PSQ layers because high energy plasma might damage 
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the backbone of PSQ, and therefore reduce the bonding strength. The proper duration was also 
critical, since long duration of plasma treatment might reduce the effective number of silanol 





Fig 3.3 Schematic cross-section of  fabrication on fused silica at the green line 
shown in Fig 3.1b.  
The microchannels and nanogaps are approximately 300nm deep while the main channels are 
approximately 3 µm deep. Oxide deposition (LPCVD) was used to shrink the nanogap size from 
approximately 250 nm to approximately 30 nm. The nanofluidic device was sealed with a PSQ 




 After plasma treatment, two silica wafers were brought into contact immediately and 
additional pressure was applied manually to confirm good bonding. If asymmetric plasma 
treatment was applied (only the wafer with PSQ was treated), the bonding was weaker than that 
after symmetric plasma treatment. PSQ has similar bonding chemistry as PDMS, and has been 
used for sealing processes in microfluidic devices [56,120,121]. However, PSQ has higher strength 
and is less likely to collapse into our low aspect ratio microchannels (~30 µm x ~100um x ~300 
nm).  Commercially available PSQ is also more amenable to dilution and spin-coating, since 
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commercially available PDMS usually has two components and the base solution is too viscous 
for spin-coating a thin layer.  
 
 After sealing, the wafer was diced into chips and ready to use. While using the devices, we 
could either glue commercially-available tube adaptors onto the through-hole reservoirs or bond 
another layer of PDMS with four through-holes for tubing connection. Note that Fig 3.3 only 
shows the complete fabrication process for the second proposed method in Fig3.2b, since the e-
Beam lithography approach (Fig 3.2a) was not successful (see Results and Discussion). 
 
3.2.3 Conjugating biotin onto the channel surfaces 
Since our final goal was to perform immunoassays in this preconcentrator, we tried to 
functionalize the silica surface with biotin to mimic the antibody-antigen binding in immunoassays. 
We tried two different surface chemistries. The protein patterning strategy using Ge as a sacrificial 
layer, described in Chapter 2, was also used to pattern the biotin molecules only in enrichment 
zone so that the bioconjugation would not affect the sealing steps afterward.  
 
The first conjugation chemistry uses (3-Aminopropyl)triethoxysilane (APTES, Sigma-
Aldrich, St. Louis, MO) to provide amine groups on the surface, followed by the treatment with 
N-hydroxysuccinimidobiotin (NHS-Biotin, Thermal Fisher Scientific, Waltham, MA) for biotin 
conjugation. In detail, 4% APTES in acetone was added onto the Ge patterned silica chips and 
incubated for 15 min at room temperature, followed by rinsing in acetone, IPA and water. Ge was 
patterned on the surface, and only the areas near nanochannels were open for bioconjugation as 
shown in Fig 3.8a1 & b1(Grey boxes indicates the bioconjugation areas). APTES formed covalent 
bonds with silica surface and provided prime amine for further bioconjugation. Then, 20mM NHS-
Biotin in dimethylsulfoxide (DMSO) was added onto the device surface for a 30 min incubation 
at room temperature. NHS groups in this solution formed covalent bonds with the prime amine 
groups on the APTES molecules, so the biotin molecules were covalently bound on the silica 
surfaces after this step. The biotinylated surfaces were washed in water and stored at 4 oC for 
further treatment, such as Ge removal in diluted H2O2 and sealing steps before use. 
 
The second surface chemistry is similar to the one in Chapter 2, using silane-PEG-biotin 
(Nanocs, New York, NY ), which is a commercially-available crosslinker using PEG as the spacer. 
On one side of the PEG molecules, there are silanol groups, which can condense with other silanol 
groups on silica surfaces to form covalent bonds. On the other side of the PEG molecules, there 
are biotin molecules to provide binding sites for streptavidin. In short, we incubated the Ge 
patterned substrates with 25 mg/ml silane-PEG-biotin in ethanol/water solution (95% ethanol and 
5% water) for 30 min at room temperature. Then, excessive silane-PEG-biotin molecules were 
washed away with DI water. Note, the 5% DI water in the silane-PEG-biotin solution and the DI 
water used for washing were not enough to effectively dissolve the Ge layer. Then the biotinylated 
surfaces were stored at 4 oC, and the following treatments were the same as above.  
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3.2.3 Conjugating antibodies onto the channel surfaces 
 In order to perform protein detection other than streptavidin, we needed to immobilize 
antibodies (instead of biotin) onto the surface before sealing. The sealing process required the two 
surfaces to be dry and clean, so we needed to verify that the drying process would not deactivate 
the antibodies. In this experiment, we used similar surface chemistry as the sections above to 
conjugate antibodies into microchannels, except that instead of using silane-PEG-biotin, we used 
silane-PEG-NHS (Nanocs, New York, NY).  
 
 First, a silica wafer was patterned with a 50 nm thick layer of Ge. The pattern used here 
had no relation with our previous device. We reused an old mask to get some openings on the Ge 
layer. The silica wafers were sliced into chips so that we could perform different experiments on 
different chips. The silane-PEG-NHS was diluted in ethanol/water solution (95% ethanol and 5% 
water) to the concentration of 25 mg/ml. The higher concentration of silane-PEG-NHS might lead 
to a better result. Due to the limited availability of this chemical, we used a lower concentration.  
 
 Silane-PEG-NHS solution was added onto the Ge patterned substrates for a 15min 
incubation at room temperature, followed by rinsing with ethanol and water. Immediately after 
washing away excessive crosslinkers, antibody solution (500 µg/ml) was added onto the substrates 
and incubated for 2 hrs at room temperature. The NHS groups on crosslinkers attacked amine 
groups on the antibodies to form covalent bonds. The processes after silane-PEG-NHS incubation 
had to be quick since NHS would hydrolyze slowly in water. The antibody we used here was 
purified rat anti-mouse-IL6 IgG (BD Bioscience, San Jose, CA), commonly used as the capture 
antibody in sandwich immunoassays. After antibody immobilization, the silica substrates were 
washed and separated into two groups. One group of silica substrates was kept wet by storing in 
1X PBS, while the other group was blown dry to test the effect of the drying process on the 
antibody activity. 
 
3.2.4 Conjugating antibodies onto microbeads 
 Since the surface conjugation of antibodies in microchannels were not very successful (see 
Results and discussion). Thus, we also investigated the antibody conjugation on bead surfaces. We 
used conventional EDC (1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide, Thermo Fisher 
Scientific, Waltham, MA) and Sulfo-NHS (N-hydroxysulfoxuccinimide, Thermo Fisher Scientific, 
Waltham, MA ) chemistry to conjugate IgG molecules onto commercially available carboxyl 
group-coated polystyrene microbeads (~4.6 µm diameter, Spherotech, Lake Forest, IL). First, 0.5% 
w/v microbeads were mixed with EDC and Sulfo-NHS for 15min at room temperature. We tested 
different concentration of EDC and Sulfo-NHS (1x: 0.6mg/ml EDC + 1.2mg/ml NHS; 0.02x : 
12µg/ml EDC + 24µg/ml NHS) in order to get the optimal conjugation on beads. Then the 
microbeads were centrifuged and resuspended in DI water with 0.1% Tween-20 to remove 
unreacted crosslinking molecules. Tween-20 was added to reduce bead aggregation and bead 
adsorption on centrifuge tubes. These washing steps were repeated for 3 times. Since sulfo-NHS 
hydrolyzes in water, the washing steps had to be fast. After the last wash, the microbeads were 
resuspended in 500µg/ml anti-IL6 capture antibody (BD Biosciences, San Jose, CA ) solution for 
2h at room temperature. After the incubation with the antibody, the reaction was stopped by adding 
hydroxyl amine (Sigma-Aldrich, St. Louis, MO) into the mixture and incubating for 10 min. Then, 
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the microbeads were washed for 3 times again. The microbeads were ready to use after blocking 
in 1% BSA (bovine serum albumin, Thermo Fisher Scientific, Waltham, MA ) for 1 hr. The 
blocking step could significantly reduce unspecific binding. (see Results and discussion) 
 
3.2.5 Instruments 
 An inverted fluorescent microscope (Nikon Eclipse Ti, Nikon Instruments Inc, Melville, 
NY) was used for all the fluorescent images. The images of enrichment and immunoassays were 
taken with the anode connected to the left reservoirs and the cathode connected to the right 
reservoirs. Platinum wires (0.13mm in diameter, A-M System, Sequim, WA) were used as 
electrodes. The DC voltage from a waveform generator (Keysight, Santa Rosa, CA) was amplified 
by a fixed gain amplifier (Tegam, Geneva, OH) before applied to the devices. ImageJ was used 
for all the fluorescent image analysis. A ZEISS Gemini Scanning Electron Microscope (ZEISS, 
Oberkochen, Germany) was used to image submicron features (EHT=2kV). For contact angle 
measurement, a drop of DI water was added onto the surface first, and a Kruss Contact Angle 
Measuring System (Kruss, Matthews, NC) was used to measure the contact angle.  
 
3.3 Results and Discussion 
3.3.1 PMMA cannot be removed after RIE 
 After E-Beam lithography and RIE etch, nanochannels were imaged using a scanning 
electron microscope (SEM). As shown in Fig 3.4a,b, the silica surface was not clean, and there 
were many residues left on the surface. These residues compromised the bonding between silica 
and PSQ surfaces and resulted in leaking.  
 
 We hypothesize that these were PMMA residues that could not be removed by organic 
solvent (Remover PG, MicroChem, Westborough, MA). We tried to remove PMMA by cleaning 
in piranha solution at 120 oC for 2 hrs, but piranha could not remove these residues as shown in 
Fig3.4c. Then, high power oxygen plasma treatment was used for further cleaning. With 30s high 
power oxygen plasma (~900W), the surface became much cleaner and smoother, although there 
were still some residues left (Fig 3.4d). Then, the same oxygen plasma cleaning process was 
repeated for another 5min. PMMA could be removed successfully, but the nanostructure was also 
sputtered away by oxygen radicals, which in turn enlarged the nanochannels (Fig 3.4e,f).   
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Fig 3.4 SEM of nanogaps fabricated with E-Beam lithography.  
(a) SEM of the nanogap, approximately the area highlighted by red box in Fig 3.1b. (b) Close-
up of the nanogap in the green box in (a). The surface is not clean and smooth, because there 
are a lot of PMMA residues left on the surface. (c) SEM of the nanostructure after 2 hrs cleaning 
in piranha solution at 120oC. The RIE process probably hardened PMMA so that piranha 
solution could not remove these residues anymore. (d) SEM of nanostructure after high power 
(900W) O2 plasma cleaning for 30 s. Short O2 plasma could partially remove PMMA residues. 
(e) SEM of the nanostructure after higher power (900W) O2 plasma cleaning for 5 min. (f) Close-
up of the nanostructure in (e). PMMA could be removed successfully by O2 plasma but the 
nanostructure was also sputtered away by O2 radicals. Note that SEM in (a) is rotated 90o 
compared to the images in (b)-(f). 
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 These results showed that it was less likely that these residues were pure PMMA because 
it was too hard to remove. It was possible that the oxide RIE process passivated the PMMA 
residues and laid down a layer of Teflon like material. It was known that silicon oxide etching with 
C4F8, which was included in our process, might have polymer deposition during etching.[123] 
However, it must not be the polymerization process alone leading to the passivation. PMMA must 
play an important role in this phenomenon because the same etching process did not result in 
passivation of DUV photoresist (UV210-0.6) as described in the following session. Thus, further 
investigation is needed to identify the material composition and reasoning of this passivation 
phenomenon. Thus, we concluded that E-beam lithography (Fig 3.2a) might not be the best 
fabrication process for our purpose. It required a lot more work in parameter tuning in the etching 
process, which was not the goal of our project. In addition, E-beam lithography had very low 
throughput, compared to the process of the second method (Fig 3.2b).  
 
3.3.2 Oxide deposition can successfully reduce nanochannels  
After the E-Beam lithography method failed, we tried to fabricate ~250 nm wide and ~300 
nm deep nanochannels with DUV and RIE on silica substrates, and then used oxide deposition to 
shrink the nanochannel width from 250 nm down to ~30 nm (Fig 3.2b). We chose to start from 
250 nm because this was the resolution limit of our exposure tool, ASML 5500/300. As shown in 
Fig 3.5a,b, the nanochannel was approximately 280 nm after etching. This nanochannel could be 
shrunk down to ~25 nm (Fig 3.5c-e). Note, the silica surface from this fabrication process was free 
of residues. DUV photoresist (UV210-0.6) was passivated during the etching process since 
common organic solvent could not strip away the residual photoresist. However, all photoresists 
(including the anti-reflective coating) could be removed completely using oxygen plasma asher 
(Matrix Plasma Asher Model 106) followed by piranha cleaning at 120 oC for 10 min.  
 
3.3.3 Single nanochannel can induce ICP based protein enrichment 
 After fabricating the first single-nanochannel preconcentrator, we tested it with Alexa-
Fluor 647 conjugated streptavidin (Strep-647, Thermal Fisher Scientific, Waltham, MA). The 
solution loaded in this very first preconcentration experiment was composed by 20ug/ml strep-647, 
0.075%BSA, and 0.1% Tween-20 in 1X PBS. We applied 25V DC voltage across the 
nano/microchannels through the reservoirs with the anode on the left and the cathode on the right. 
As shown in Fig 3.6, strep-647 was successfully enriched in front of the single nanochannel, and 
there was a depletion zone adjacent to that nanochannel. The image in Fig 3.6 was taken after one 
min of enrichment, and the signal in the enrichment zone was saturated, which represented >1 
mg/ml of strep-647. Thus, we achieved more than 50 fold enrichment in one min.  
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Fig 3.5 SEM images before and after oxide deposition.  
SEM images before (a)&(b) and after (c)-(e) oxide deposition, approximately the area 
highlighted by red box in Fig 3.1b. In (a),(b),and (e) Images were taken at 90o, while in (c) and 
(d) the sample was tilted for 40o. The nanogap size was reduced from approximately 280 nm 
down to 25 nm. Note that these sizes are slightly off compared to the design in Fig 3.1. This is 
probably due to the fabrication and measurement error.  
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Fig 3.6 ICP based preconcentration in front of a single nanochannel.  
Sample solution was composed by 20ug/ml strep-647, 0.075%BSA, and 0.1% Tween-20 in 1X 
PBS. A DC Voltage (25V) was applied across the nanochannel with anode on the left and 
cathode on the right.  
 
3.3.4 Silane-PEG-Biotin is a better crosslinker for surface functionalization 
than APTES 
Since our final goal was to perform immunoassays in this preconcentrator, we tried to 
functionalize the silica surface with biotin to mimic the antibody-antigen binding in immunoassays. 
We tried two different strategies for biotin conjugation in channels: 1) using APTES along with 
NHS-biotin and 2) using silane-PEG-biotin. Both of these two surface conjugation methods could 
successfully conjugate biotin onto the silica surface, but both of them changed the hydrophobicity 
of the surface as shown in Fig 3.7. The first strategy (APTES+NHS-biotin) resulted in more 
hydrophobic surfaces, compared to the bare silica surfaces. The contact angle after the treatment 
of APTES and NHS-biotin (contact angle = 68.8o) was approximately twice as large as the contact 
angle of bare silica (contact angle =35.2o). However, the second strategy (using silane-PEG-biotin) 
reduced the contact angle by approximately 35%, making the surfaces more hydrophilic, which 
due to the hydrophilic PEG spacer. Since our microchannels were only ~300 nm deep, a 
hydrophobic surface would prevent solution loading into the channel. Thus, we decided to use 
silane-PEG-biotin for streptavidin detection in our preconcentration device.  
 
 
    38
 
Fig 3.7 Contact angle of glass surface with different surface chemistry.  
The use of APTS resulted in a more hydrophobic surface than bare glass, while the PEG 
crosslinker led to a more hydrophilic surface. A hydrophilic surface is better for sample loading 
into the microchannels and nanogaps.  
 
 
3.3.5 Multi-nanochannel design leads to faster analytes accumulation due to 
higher electroosmotic flow 
After conjugating biotin in front of the nanochannels (grey areas in Fig 3.8a1), the 
preconcentrators were sealed and tested with strep-647.  We tested the detection of strep-647 in 
single-nanochannel preconcentrator by loading sample solution (20 ng/ml strep-647, 0.75% BSA 
and 0.1% Tween in 1X PBS) and applied 25V DC voltage for 15 min. As shown in Fig 3.8a3, the 
detection zone has a higher fluorescent intensity than the background, meaning 20 ng/ml strep-647 
could be detected successfully.  
 
However, given the high affinity of streptavidin-biotin pairs, this result was not good 
enough, since our target was to get sub-picomolar sensitivity in tens of minutes. We could detect 
20 ng/ml strep-647 in 15min by simply adding sample solution on top of the biotinylated surface 
without preconcentration. Since all molecules accumulated in the enrichment zones are carried by 
electroosmotic flows from the bulk areas to the enrichment areas, the low volumetric flow in 
single-nanochannel devices may be the reason for low sensitivity. If we assume no molecule 
leaking into the downstream, the enrichment speed should be proportional to the electroosmotic 
flow, although this is not completely true[62]. This is partially proved by the fact that higher DC 
voltage induces faster enrichment in Chapter 4 since the electroosmotic flow rate is proportional 
to the electric field. Again, this is not completely true, since the voltage also affects the ICP 
development[62], but at least in the range of the voltages we tested, it shows this linear relationship 
approximately (details in Chapter 4).  
 
As shown in Fig 3.8a2, the single nanochannel design induced two small enrichment zones. 
Although the intensity in these two small enrichment zones was 50 times higher than the 
background after 1 min enrichment, the total number of molecules enriched was still very limited. 
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Note, the sample solution in Fig 3.8a2 had 20 µg/ml strep-647 for a better demonstration of the 











Fig 3.8 Single vs multiple nanochannels enrichment.  
(a1) & (b1), single-/multiple-nanochannel designs and biotin conjugation areas. The red lines 
are the outline of the nanostructure and the grey squares are the biotin conjugation areas 
(detection zone). Both single-nanochannel (a2) and 24-nanochannel (b2) design were used to 
enrich 20 µg/ml Strep-647 with 0.75% BSA and 0.1% Tween in 1X PBS at 25V. Both images (a2 
& b2) were taken after 1 min enrichment. Multi-nanochannel design led to much larger 
enrichment zone, indicating more strep-647 accumulated in the detection zone. (a3) & (b3) 20 
ng/ml strep-647 was detected with the single-nanochannel (a3)and the multi-nanochannel 
design (b3). Multiple nanochannels accumulated more strep-647 molecules and resulted in 
higher intensity in detection zone. (c) The top view of the multi-nanochannel design. 
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Then, we tried to increase the volumetric flow by increasing the number of nanochannels. 
Increasing the number of nanochannels per microchannel does not increase the flow rate in each 
nanochannel since the linear velocity of electroosmotic flow should only be affected by the electric 
field and zeta potential of the surface. However, the total volumetric flow in each microchannel is 
proportional to the number of nanochannels per microchannel, assuming that the flow rate in each 
nanochannel remains the same.  
 
As shown in Fig 3.8b1, we designed 24 nanochannels in each microchannel. In this design, 
all the fabrication process and the depth of nano/microchannels were the same as for the single-
nanochannel design, so that we didn’t need to change any fabrication parameters for the new design. 
We used the multi-nanochannel design to enrich 20 µg/ml strep-647 in 1X PBS with 0.75% BSA 
and 0.1% Tween at 25V (Fig 3.8b2). The 23 micropillars formed 24 nanochannels in the middle 
of each microchannel(Fig 3.8c). These micropillars (1µm by 1µm) have the same height as the 
microchannel sidewalls (~300 nm).  Compared to the enrichment with single nanochannel design 
(Fig 3.8a2), multichannel design induced much larger enrichment zone with more molecules 
accumulated. We also repeated the experiment in Fig 3.8a3. Multi-nanochannel design resulted in 
much higher intensity for 20 ng/ml strep-647 under the same enrichment setting (Fig 3.8b3). This 
result demonstrated the fact that higher volumetric flow resulted in faster accumulation of protein 
molecules. 
 
3.3.7 Multi-nanochannel design can detect 2 ng/ml strep-647 in 10 min 
 After confirming that multi-nanochannel design resulted in faster protein enrichment, we 
used this design to detect strep-647 at various concentrations (Fig 3.9).  Strep-647 was diluted in 
1X PBS with 0.75% BSA and 0.1% Tween-20. Both BSA and Tween-20 were used to reduce the 
unspecific binding on channel walls. We applied 25V through reservoirs with the anode on the left 
and the cathode on the right. As shown in Fig 3.9, 2 ng/ml strep-647 could be detected after 10 
min enrichment and the signal saturated after 5 min enrichment of 200 ng/ml strep-647. The 
intensity was quantified along the orange lines in Fig 3.9. Fig 3.10a shows the intensity of 2 ng/ml 
strep-647 detection after 10 min and 20 min enrichment at 25V. Fig 3.10b shows the intensity of 
strep-647 detection at various concentrations with 10 min enrichment at 25V. These results 
demonstrate that 1) immunoassays can be integrated into preconcentrators; 2) multi-nanochannel 
design and higher electroosmotic flow accelerate enrichment.  
 
 








Fig 3.9 The detection of streptavidin at various concentrations and enrichment 
times.  
All the experiments were performed in 1x PBS with 0.75% BSA and 0.1% Tween and Strep-647 
was enriched under 25V DC voltage. Images for 38pM were enhanced for 40% of brightness 
for a better demonstration.  
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3.3.7 Blow dry process deactivates antibodies on the substrates 
 In order to perform protein detection other than streptavidin, we needed to immobilize 
antibodies (instead of biotin) onto the surface before sealing. The sealing process required the two 
surfaces to be dry and clean. However, the drying process deactivated the antibody (Fig 3.11).  
 
 
Fig 3.10 Detection of fluorescent streptavidin with multichannel enrichment.  
(a) 2 ng/ml Strep-647 detection with 10min & 20min enrichment under 25V. (b) Strep-647 
detection at various concentrations with 10min enrichment under 25V. These measurements 
were made along the orange lines in images in Fig 3.9. 
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We used 3 types of secondary antibodies (2nd Ab) to verify the immobilization of the first 
antibody on the substrates. The 2nd Ab 1 (clone G28-5, BD Bioscience, San Jose, CA) and 2nd Ab 
2 (clone RG11/39.4, BD Bioscience, San Jose, CA) were both FITC conjugated monoclonal 
secondary antibodies. The 2nd Ab1 and Ab2 specifically target to IgG1/2a and the Fc region of 
IgG1. Both of these two secondary antibodies showed fluorescent signals in the wet group (Fig 
3.11a,c) but no signals in the dry group (Fig 3.11b,d). This indicated that our antibody 
immobilization process was successful, but the blow-dry process deactivated the capture antibody.  
 
The 2nd Ab 3 (Goat anti-Rat IgG Cross-Adsorbed Secondary Antibody, Thermal Fisher 
Scientific, Waltham, MA) was an Alexa Fluor 546 conjugated polyclonal secondary antibody, 
which was less specific than the 2nd Ab 1 and 2nd Ab 2. This secondary antibody showed signal in 
both groups (Fig 3.11g,h), indicating that the primary-antibody molecules were still on the 
substrate after blowing dry. The blow-dry process might partially change the folding or the 
structure of the immobilized IgG. Thus, the polyclonal 2nd Ab 3 (binding to both heavy and light 
chains) could still bind to those dried IgG, while the secondary antibodies (2nd Ab 1 and 2nd Ab 2) 
with higher specificity could not.  
 
We also tested the activity of the immobilized antibody by adding its antigen (2 µg/ml IL6) 
followed by loading of the detection antibody (Biotin Rat Anti-mouse IL6, BD Bioscience, San 
Jose, CA) and Strep-647. If the immobilized capture antibody still maintained its affinity to its 
antigen (IL6) despite the effect of drying, detection antibody could still bind to the captured IL6 
molecules and in turn fluorescently labeled by strep-647. However, only the wet group showed 
fluorescent signals in this sandwich assay, and the dry group showed no signals at all (Fig 3.11e,f). 
Thus, our results showed that we had successfully conjugated primary antibody onto the silica 
substrates, but the drying step required by the following sealing process deactivated our 
immobilized antibody. Note that we didn’t even dissolve the Ge layer after immobilization. The 
diluted H2O2 was also expected to deactivate the IgG by oxidation.  
 
In addition, due to the surface bioconjugation, only the PSQ wafer could be plasma treated. 
This asymmetric plasma treatment lowered the bonding strength and increased the ratio of leaking 
devices. Thus, we concluded that surface functionalization might not be a good choice for our 
preconcentration device unless the activity of antibodies could be maintained during the drying 
process or another bonding process could be applied without drying the surface. Therefore, we 
used antibody conjugated microbeads in our next-generation devices (Chapter 4).  
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Fig 3.11 Drying process deactivated antibody for analyte capturing.  
The 2nd Ab 1&2 are the antibodies specifically targeting to the light chains of IgG molecules, 
which are the binding sites of antibodies. No fluorescent signals from 2nd Ab1&2  after blowing 
dry the surface (b)&(d) suggested the deactivation of capture antibodies on the surface. The 
absence of signals in (f) confirmed this result. The 2nd Ab 3 targets to both heavy chains and 
light chains of antibodies, and the signal in (g) &(h) demonstrated the successful conjugation 
of capture antibodies on the surfaces. The blow-dry process only deactivated the antibody and 
the main IgG molecules were still on the surface.  
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3.3.8 Antibody conjugation on microbeads  
 After conjugating anti-IL6 antibody onto the microbeads by EDC/NHS chemistry, we 
verified the conjugation by using 2nd Ab1 and Ab3 (same as section 3.3.7), as shown in Fig 3.12 
and Fig 3.13. With both 2nd Ab1 and Ab3, we got strong fluorescent signals in all groups, including 
the group with no primary antibody conjugated (negative control group). The signal in the group 
of negative control showed strong unspecific binding of 2nd antibody on the surfaces of microbeads. 
To reduce unspecific binding, we blocked the microbeads with 1% BSA before incubating them 
with 2nd Ab3 (Fig 3.14). In Fig 3.14, the no-conjugation group had no fluorescent signal while 
another two groups had strong fluorescent signal, which proved that we had successfully 
conjugated the primary antibody onto the microbeads and these signals were not due to the 
unspecific binding of the 2nd antibody.  
 
 After showing the existence of primary antibody on the microbeads, we also demonstrated 
the possibility of employing sandwich immunoassays on these microbeads (Fig 3.15). We 
incubated these antibody-conjugated microbeads with 2µg/ml mouse IL6 for 1h, followed by the 
incubation with complimentary antibody (detection antibody; same as section 3.3.7) for 30 min. 
Since these detection antibody molecules were biotinylated, we incubated these microbeads with 
strep-647 to provide fluorescent signals. As shown in Fig 3.15, the 1x EDC/NHS group showed 
much higher intensity than the group of 0.02x EDC/NHS, indicating that the lower EDC/NHS 
concentration had lower conjugation efficiency and resulted in less primary antibody molecules 
on each microbead. The absence of fluorescent signal in the group of negative control proved that 
unspecific bindings did not cause all those signals in another two groups in Fig 3.15. Thus, these 
microbeads were ready for immunoassays in our preconcentration devices.  
 
3.3.9 Deep nanochannels can be fabricated on silicon substrates followed by 
oxide deposition  
Besides the problem of surface antibody stability, we also tried to enhance the analyte 
accumulation in our device even further. In section 3.3.6, we demonstrated the detection of 2 ng/ml 
strep-647, which is still not good enough, especially for those low abundance proteins like 
cytokines, whose concentrations are usually in the range of pg/ml.[124–127] As we discussed 
above, the rate of analyte accumulation should increase along with the volumetric electroosmotic 
flow. Thus, we further increased the volumetric flow rate in each microchannel by increasing the 
depth of the nano/microchannel from ~300nm to several microns. This depth was again limited by 
the aspect ratio of the etching process.    
 
To increase the depth of the nanochannels, we had to switch from silica wafers to silicon 
wafers for two reasons. 1) RIE tool for oxide etching in our lab cannot provide such high aspect 
ratio (height vs. width > 20:1). In our previous fabrication, the 250 nm wide and 300 nm deep 
nanochannels only required approximately 1:1 aspect ratio, but if we increased the depth to 10 µm, 
the aspect ratio would be 40:1. 2) The oxide etching recipe does not have high enough selectivity 
to DUV photoresist. Our inductively coupled plasma etcher uses C4F8 for silicon dioxide etching, 
and the selectivity to photoresist is approximately 4:1, meaning that the photoresist has to be >1µm 
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for a 4 µm deep etching. However, increasing the thickness of DUV photoresist from 420 nm to >1 






Fig 3.12 Labeling primary antibody on microbeads with polyclonal 2nd antibody.  
These microbeads were conjugated with primary antibody with EDC/NHS chemistry and then 
labeled by 2nd  Ab 3. This is a polyclonal secondary antibody targeting to both heavy and light 
chains of rat IgG molecules. The fluorescent signal in third group (no-conjugation group) 
showed strong unspecific binding on beads.  
 




Fig 3.13 Labeling primary antibody on microbeads with monoclonal 2nd 
antibody.  
These microbeads were conjugated with primary antibody with EDC/NHS chemistry and then 
labeled by 2nd  Ab 1. This is a monoclonal secondary antibody targeting to IgG1/2a specifically. 
The fluorescent signal in third group (no-conjugation group) showed strong unspecific binding 
on beads. 
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Fig 3.14 Blocking with BSA prevented the unspecific binding on microbeads.  
These microbeads were conjugated with primary antibody with EDC/NHS chemistry and then 
incubated with by 2nd  Ab 3. The absence of fluorescent signal in the third group (no-conjugation 
group) proved that BSA could significantly reduce unspecific binding, and the signals in the first 
















Fig 3.15 Sandwich assay on microbeads.  
These microbeads were conjugated with anti-IL6 primary antibody with EDC/NHS chemistry 
and then incubated with 2µg/ml IL6. After washing away excessive IL6 molecules, the 
microbeads were incubated with detection antibody and strep-647 to label the captured IL6 




Since we switched substrates, it was necessary for us to find the proper tool and recipe to 
etch silicon with high aspect ratio. We used a pattern similar to the one in Fig 3.8b2, except that 
there were only 12 nanochannels per microchannel (instead of 24 nanochannels in Fig 3.8b2). The 
pillars were designed to be 600 nm x 400 nm, and the gaps between pillars were 250nm. We first 
etched the silicon substrates with a transformer-coupled plasma etching system (LAM TCP 
9400SE) using Cl2(50 sccm) and HBr (150 sccm). As shown in Fig 3.16, after a ~4 µm etch, six 
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out of eleven pillars fell. The pillars were highly tapered since the etching profile was not perfectly 
90o. The pillars fell during the etching process because the highly tapered bottoms could not 
support the larger upperparts. This effect was not noticeable, until decreasing the feature size down 
to sub-micron scale. Thus, this etching process does not fulfill our requirements for high-aspect-
ratio nanochannels.  
 
 
Fig 3.16 Silicon etching with Cl2 in TCP 9400 does not have high enough aspect 
ratio.  
These pillars were designed to be 600 nm x 400 nm in lateral. The pillars were approximately 4 
µm tall, same as the depth of the trench in this image. The gap between pillars were designed to 
be 250 nm. This is a top view SEM. We can see the sidewalls of pillars in this SEM because some 
of the pillars (6 out of 11) fell. This etching recipe resulted in tapered pillars (negatively tapered 
trench between pillars).  
 
 
Then, we started trying to use DRIE (or Bosch process) in an inductively coupled plasma 
etcher (SPTS Technologies, Newport, UK). The DRIE process alternates etching and deposition 
steps using SF6 and C4F8 plasma, respectively.[128–132] The first step is usually to deposit a 
passivation layer to protect the sidewalls, and the second step is to etch away the polymer and the 
silicon. Since the etch rate on the bottom of the trench is greater than the rate on the sidewalls, the 
passivation polymer can effectively protect the sidewalls, while the silicon on the bottom is etched. 
This alternating mechanism results in highly anisotropic profile, although the SF6 plasma etching 
is isotropic.  
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However, the isotropic etching causes rippled sidewalls as shown in Fig 3.17a,b (adapted 
from Jae-Ho Min, 2005)[132]. The duration of etch and deposition determines the size of the 
ripples. Generally, the longer duration causes larger undercuts (Fig 3.17a,b). The ratio of etch to 
deposition durations determines the angles between the sidewalls and the bottom of the channels. 
A larger ratio leads to negatively tapered sidewalls (Fig 3.17c), while a small ratio causes tapered 
channels (Fig 3.17d).[132] These are the two major factors limiting the feature size under 
submicron scales, so we tuned these two factors to optimize the DRIE recipe for our purpose.  
 
 
Fig 3.17 The duration and ratio of etch and deposition determines the shape of 
sidewalls. 
(a)&(b) The longer etching duration for each cycle results in the larger size of sidewall ripples 
(larger undercut). (c) A large etch to deposition ratio leads to negatively tapered channel， 
while a smaller etch to deposition ratio (d) leads to tapered channels. 
 
 
As shown in Fig 3.18, all pillars were completely etched away when we applied 5 s 
deposition and 7 s etching. The feature design was exactly the same as Fig 3.16 and the complete 
recipe is shown in Table 3.1. All pillars disappeared because the undercuts (ripples) were too large 
and the etched away most of the materials underneath the photoresists. Thus, we decreased the 
duration of etch and deposition to adjust the sizes of the ripples (Fig 3.19). Note, in this experiment, 
we used a layer of ~400 nm thick oxide as our hard mask. The etching process had higher 
selectivity to oxide (>100: 1) compared to the selectivity to photoresist (~50:1), since we were 
targeting to >20 µm depth at the very beginning, and a layer of ~420 nm photoresist was not 
enough for that purpose. The size of the ripples reduced from ~100 nm to ~30 nm, when we 
decreased the durations from 4 s deposition and 5 s etch to 2 s deposition and 3 s etch.  
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We finalized our process with 2 s deposition and 3 s etch because our tool could not switch 
gases fast enough to decrease the cycle times further. The sidewall profile was still negatively 
tapered, and the etching limit was around 6 µm deep (Fig 3.20a). Deeper etching (>6 µm) resulted 
in pillar falling. With this etching depth, we did not need an oxide hard mask, so we didn’t use this 
hard mask anymore in our fabrication process.  
 
 
Fig 3.18. Top view of micropillars after DRIE for 3 microns.  
Standard recipe (Passivation 5 sec / Etching 7 sec) was used in this experiment. All pillars were 
etched away and ended up without nanochannels.  
 
 
After finalizing the etching recipe, we needed to find the proper oxide deposition recipe to 
shrink the size of gaps between pillars. Since our structure had a high aspect ratio and small gaps 
between pillars, we started with thermal oxidation because it is highly conformal. Thermal 
oxidation with O2 only (dry oxidation) for 6 hrs was not enough to fill up the gaps (Fig 3.20b), so 
we added DI water steam into the furnace to accelerate the oxidation process (wet oxidation, Fig 
3.20c,d).[133,134] After a 6 hr wet oxidation, the sidewall of the trench (microchannel) swelled 
and deformed the adjacent pillar (Fig 3.20d). However, the nanochannel sizes between pillars were 
still hundreds of nanometers, one magnitude larger than our target size (30 nm). This result 
indicates that the sidewalls have a higher oxidation rate than the pillars, probably because the 
pillars do not contain enough silicon to oxidize, although more investigation is needed for a more 
accurate explanation. After dry and wet oxidation failed filling up the gaps, we used a low-pressure 
chemical vapor deposition (LPCVD) furnace (TYTAN Diffusion Furnace System, Tystar, Garden 
Grove, CA) to deposit a layer of high-temperature oxide (HTO) at 900 oC. As shown in Fig 
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13.20e,f, HTO successfully shrunk the nanochannel size down to tens of nanometers. Thus, we 
used HTO to reduce nanochannel for all the following experiments in the next chapter.  
 
 
Fig 3.19 The shorter durations resulted in the smaller ripples.  
Decreasing etching duration from 5 s to 3 sec reduces the sizes of ripples (orange arrow) from 
100 nm to 30 nm. Oxide hard mask (green arrow) was used in this experiments, since we 
expected to etch tens of microns, which would exceed the limit of depth achievable from 420 nm 
thick photoresist. After we chose ~6.5 µm as the depth of our channels (height of pillars), oxide 








An ICP based preconcentration device was developed with 24 vertical nanochannels in 
each microchannel. The multi-nanochannel device led to a >10 times higher sensitivity ( sensitivity 
increased from 20 ng/ml to 2 ng/ml) compared to the single-nanochannel device,  due to the faster 
accumulation of protein molecules resulted from the higher volumetric flow rate. To further 
enhance the electroosmotic flow in the microchannel, we switched from silica substrates to silicon 
substrates for deeper nanochannels with a high aspect ratio. By increasing the depth from ~300nm 
to 6 µm, the volumetric flow rate should increase by 20-fold with the same linear flow rate. The 
fabrication process was demonstrated for these high-aspect-ratio nanochannels on a silicon wafer. 
The next step is to enhance the performance even further by using a new design with 398 vertical 
nanochannels (instead of tens of nanochannels) per microchannel (Chapter 4). The additional 
nanochannels should provide ~20 fold improvement in volumetric flow.  Thus, this new design 
(398 nanochannels with the depth of 6 µm) can result in approximately 400-fold enhancement in 
sensitivity, compared to the multi-nanochannel design with the depth of ~300 nm. On the other 
hand, we switched from surface immunoassays to bead-based immunoassays, since antibodies 
were deactivated during the drying process, which was necessary for the sealing process. The large 
number of nanochannels in each microchannel provides enough flow rate for bead loading and 
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Fig 3.20 SEM of 6.5 µm pillars.  
SEM of pillars before (a) and after oxidations(dry oxidation(b), wet oxidation(c,d), and HTO 
(e,f)). The pillars were 550 nm by 320 nm( 600 nm x 400 nm on mask) and approximately 6 µm 
tall. The gaps between pillars were approximately 300 nm (250 nm on the mask), although the 
gap sizes at bottom are obviously larger. (b-d) Neither dry nor wet oxidation could close the 
gaps, due to the limited volume of silicon to oxidize on each pillar as well as the slow oxidation 
rate. HTO could successfully fill up the gap between pillars (e,f).  
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Chapter 4: Ion concentration polarization 





Adapted with permission from: 
 
1. Lu B, Maharbiz MM “Ion concentration polarization (ICP) of proteins at silicon 





 Fast detection of low-abundance protein remains a challenge because detection speed is 
limited by analyte transport to the detection site of a biosensor. In this paper, we demonstrate a 
scalable fabrication process for producing nanogaps in vertical nanochannels (nanogaps) which 
enable ion concentration polarization (ICP) enrichment for fast analyte detection. Compared to 
horizontal nanochannels, massively paralleled vertical nanogaps not only provide comparable 
electrokinetics, but also significantly reduce fluid resistance, enabling  microbead-based assays.  
The channels on the device are straightforward to fabricate and scalable using conventional 
lithography tools. The device is capable of enriching protein molecules by >1000 fold in 10 min. 
We demonstrate fast detection of IL6 down to 7.4 pg/ml with only a 10 min enrichment period 
followed by a 5 min incubation. This is a 162-fold enhancement in sensitivity compared to that 
without enrichment. Our results demonstrate the possibility of using silicon/silica based vertical 




 A number of microfluidics based immunoassays have been developed specifically for low 
abundance target molecules[135], including cantilever-based biosensors[136], surface plasmon 
resonance (SPR)[137], and nanowire-based immunoassays[34]. However, immunoassays for low 
concentration proteins remain a challenge because most existing technologies are sensitive to 
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antibody quality and require relatively long incubation times. The sensitivity of most biosensors 
depends on the affinity of the capture antibody, implying that high sensitivity biosensors require 
high quality antibodies with a very low dissociation constant, Kd. In addition, antibody-antigen 
systems require relatively long incubation times to achieve binding equilibrium. This is especially 
pronounced at low antigen concentrations [16], particularly at concentrations below the antibody 
dissociation constant as analyte transport to the biosensor becomes the rate limiting step [12–15].  
As a result, incubation times ranging from several hours to overnight are usually necessary for low 
concentration detection [138]. To overcome these limitations, many sample enrichment 
technologies have been developed in recent years; these include nano-dispensing [139], size 
exclusion [45,46], isoelectric focusing [51–54], isotachophoresis [59], amplification stacking [47–
50], and dielectrophoresis [55–58]. However, the application of these enrichment methods to 
immunoassays remains a challenge. Among the difficulties in applying these to immunoassays are 
the fact that nano-dispensing requires a complex and expensive dispensing system; size exclusion 
depends on the molecule size; sample stacking and isotachophoresis requires special buffer 
arrangements; and dielectrophoresis requires an expensive, high quality electronic amplifier with 
high slew rate, low noise, and high power. 
 
 In this context, ion concentration polarization (ICP) has captured tremendous interest in 
the field of electrokinetic preconcentration of biomolecules [1,61]. ICP-based preconcentrators do 
not require special buffers and reagents, in contrast to sample stacking and isotachophoresis. ICP 
methods accumulate biomolecules at the boundary of a depletion zone, regardless of the molecule 
size [68,76,140,141]. Since ICP-based devices only require DC voltages, they are much simpler 
and cheaper than those employing dielectrophoresis [55–58]. Because ICP is a phenomenon that 
exists at the interface between nanochannels and microchannels, ICP-based protein enrichment 
was originally achieved on silicon or glass substrates using thin horizontal nanochannels 
[16,60,64–67]. Polydimethylsiloxane (PDMS) and Nafion have also been  used for nanofluidic 
preconcentration devices because the Nafion membrane provides similar permselectivity to silica 
nanochannels and PDMS is a well-known material for prototyping microfluidics [68,70–78]. For 
example, the simplest preconcentrator employs a Nafion membrane deposited in the center of a 
straight PDMS microchannel [72]. The high difference in conductivity between the Nafion 
membranes and the PDMS microchannel induce ICP, enriching biomolecules at the anodic side of 
the Nafion film. However, this simple design is hard to replicate on silicon or silica substrates with 
horizontal nanochannels, since the horizontal nanochannels alone cannot provide sufficient 
volumetric flow for immunoassay operations such as sample loading and washing. Thus, in most 
silicon/silica preconcentrators the horizontal nanochannels must be perpendicular to larger 
microchannels [16,60,64,66], which results in a more complex structure. Importantly, while 
PDMS/Nafion devices are excellent for prototyping (i.e. production in the tens of devices per day), 
silicon/silica-based devices are easier to scale up to high volumes (i.e. tens of thousands of devices 
per day) given modern photolithography tools and processes.   
 
 In this paper, we demonstrate a silicon/silica based preconcentration device with 397 
micropillars forming 398 vertical nanogaps between them. The presented process has specific 
advantages when compared to previous silicon/silica nanochannel designs which require 
horizontal nanochannels as well as polymer membrane devices. One of the advantages of the 
silicon / silica fabrication process presented in this paper is that it allows for a design in which 
both the microfluidics and nanopillar concentrators are fabricated simultaneously and in-plane. 
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The large number of nanogaps that can be fabricated in parallel in one flow channel, coupled with 
a short channel length (1 µm) provide sufficient volumetric flow to allow for this simple design. 
Taken together, the nanogaps act as a silicon/silica-based membrane in-line with the microchannel 
flow. The only comparably simple design previously reported requires a Nafion-based 
preconcentrator [72]. Compared to polymer membrane devices, the presented fabrication process 
is more compatible with conventional lithography tools and cleanroom processes, making it 
amenable to scale-up to high volumes [16,60,64–67].  
 
 Furthermore, a combined pre-concentrator / filter design allows for bead-based 
immunoassays, as the micropillars both induce ICP and stop functionalized beads in the ICP 
enrichment zone. In contrast, most previously reported designs use separate features to perform 
enrichment and capture beads. For example, in Wang et al. [16], an additional shallower channel 
was fabricated to stop microbeads in front of the silica-based horizontal nanochannels; this requires 
additional mask alignment and etching steps. Likewise, in Ko et al. [71], additional sets of pillars 
were fabricated into their device to capture beads in front of Nafion membranes. 
 
 In our device, the coupling of ICP and electroosmotic flow (EOF) results in the 
accumulation of biomolecules in front of the pillars (detailed schematic diagram of mechanism in 
Fig 4.1). In effect, the array of nanogapped pillars mimics the function of a semi-permselective 
membrane that prefers to transport cations rather than anions, given that the silica surface is 
negatively charged in phosphate buffered solution (PBS) at pH=7.4. The permselectivity of silica 
nanogaps originates from surface conduction through the electrical double layer (EDL), which in 
microchannels is usually overwhelmed by bulk conduction. However, surface conduction becomes 
significant when the channel size is comparable to the thickness of the EDL. For example, if one 
were to fabricate nanoscale channels, the ratio of EDL thickness to channel width would increase 
by three orders of magnitude when compared to the effect in a microscale channel. It follows that 
the ratio of surface conductivity to bulk conductivity would also increase by three orders of 
magnitude (Dukhin number [46]).  
 
 Note that our nanogaps do not perform as a perfect ion selective membrane. The thickness 
of the EDL with 0.1X and 1X PBS is approximately 3 nm and 0.8 nm [61,64], respectively, both 
of which are significantly smaller than the size of our nanogaps (30 nm). There are two relevant 
conduction phenomenon in our nanogaps: bulk conduction - transporting both cations and anions 
and surface conduction - transporting mostly cations through EDL. At this scale (channel width 
~10x larger than EDL thickness), the cations transported by surface conduction initiate a weak 
concentration polarization and decrease ion concentration on the anodic side of the nanostructure 
[1,61]. The lower ion concentration near the nanogaps increases the thickness of local EDL and 
enhances permselectivity which contributes to faster concentration polarization. Thus, the 
concentration polarization in our device depends on a positive feedback process [61] which 
develops strong ICP even at moderate (0.1X PBS, ~15 mM) ionic strength (i.e. buffers for which 
the Debye length is significantly shorter than the nanogap width). The low ion concentration region 
(depletion zone) induces nonequilibrium space charge layers, resulting in accelerated 
nonequilibrium EOFs in the vicinity of the nanostructures [64,142,143]. Due to the 
incompressibility of the fluid, strong vortical flows are generated in the depletion zone, driving the 
fluid back to the upstream [1,61,144,145]. At the same time, the low ion concentration amplifies 
the electric field in the depletion zone, repelling negatively charged biomolecules away from the 
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nanostructures. The backflow of the vortices along with the strong electric field work jointly to 
move biomolecules upstream until the convective and electromigratory velocity balance, resulting 
in the continuous accumulation of biomolecules (Fig 4.2h) [62,144].  
 
 To demonstrate the bead immunoassay possibilities of our device, we chose interleukin 6 
(IL6). IL6 is a proinflammatory cytokine and serves as an important mediator during the acute 
phase response to inflammation in sepsis. Its concentration in blood is used as a diagnostic for 
sepsis [19,20] and is significantly positively correlated with septic patient mortality rate [21]. As 
a life-threatening disease caused by systemic immune response, septic patients usually need 
immediate treatment. The ability to monitor IL6 levels time scales in the tens of minutes would 
open the door to closed loop, patient-specific sepsis management [55–57]. 
 
4.3 Device Fabrication  
  
 The preconcentration device is formed from two parallel channels connected by 
microchannels which contain the nano-gapped pillars;  four reservoirs provide tubing and electrode 
connections (Fig 4.2a). During enrichment, one channel (left) is connected to the anode while the 
other channel (right) is connected to the cathode. As shown in Fig 4.2(b-d), the microchannels are 
700 µm long, 30 µm wide and 6.5 µm deep and contain 397 micropillars. Each micropillar has a 
cross section of approximately 1 µm by 1 µm and the same height as the microchannels. The gaps 
between micropillars are 30 nm wide, forming 398 nanogaps.  
 
 
Fig 4.2 Overview of the preconcentration device.  
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(a) Schematic diagram of the entire device. Two main channels (each with two reservoirs) are 
connected by the microchannels with nanogaps in the middle. The reservoirs are used to connect 
external fluidic tubing with the microchannels and to provide contact with electrodes. (b) Close-
up of the microchannels connecting the two main channels. These microchannels are 700 µm 
long, 30 µm wide, 6.5 µm tall, and contain 397 micropillars at one end. Nanogaps between 
micropillars are approximately 30 nm wide and induce ICP to enrich target proteins. (c) Top 
view. (d) 30o off-axis. SEM of the nanostructures in the blue box in (b). There are in total 397 
micropillars (1um x 1 um x 6.5 um) forming 398 nanogaps. (e)-(g) Pictures of finished chips. 
Each chip has three layers, PDMS layer for tube connection, silicon layers with all the 
micro/nano structures, and silica layer for sealing purpose. (h) Schematic of ICP and protein 
enrichment in front of nanostructures with the anode on the left side.  
 
 All structures are fabricated in the silicon substrate. We chose silicon micromachining 
instead of PDMS molding because a high aspect ratio is achievable when etching silicon. The 
finished devices have three layers as shown in Fig 4.2e & 1f. The fabricated silicon device is sealed 
with a silica wafer spin coated with polysilsesquioxane (PSQ) and this transparent side enables 
fluorescence detection. A thick layer of PDMS with four through-holes is bonded on the other side 
of the silicon layer to form the reservoirs for tube and electrode connection (Fig 4.2g).   
 
 Microchannels (including micropillars) were fabricated on a p-type prime silicon wafer 
(Fig 4.3a). A 420nm thick layer of deep ultraviolet (DUV) photoresist (UV210-0.6, Dow Chemical, 
Midland, MI) was spun on a silicon wafer and then exposed in ASML 5500/300 (ASML, 
Veldhoven, Netherlands).  The exposed photoresist was then developed in Megaposit MF26A 
(Dow Chemical, Midland, MI) and hard baked for 2 hrs at 120oC. The silicon wafer was etched 
6.5 µm deep with deep reactive-ion etching (DRIE) in an ICP (inductively coupled plasma) etcher 
(SPTS Technologies, Newport, UK). Ideally, deeper nanogaps would give better results, but we 
were constrained to 6.5µm depths by the aspect ratio limits of the etch recipe. After spin coating a 
10 µm thick layer of photoresist (SPR 220-7.0, Dow Chemical, Midland, MI) to protect surface 
structures, reservoirs were ground manually with a dental drill to create access holes through the 
silicon. This step could be replaced by RIE or KOH etching for scaled up manufacturing [16,60]. 
Because the minimum lithographically-defined linewidth was 250 nm (Fig 4.3b & 2d), the next 
step was to shrink the nanogaps from 250 nm to ~30 nm by oxide deposition. Since we had high 
aspect ratio structures, a highly conformal deposition process was used to achieve uniform 
deposition over the micropillars. We deposited a layer of high-temperature oxide (HTO) at 900o C 
over the etched devices with a TYTAN Diffusion Furnace System (Tystar, Garden Grove, CA) to 
achieve ~30 nm wide nanogaps (Fig 4.3c & 4.3e). Note, it is important to deposit oxide after 
reservoir grinding. Otherwise, the newly grinded reservoirs would expose the conductive silicon 
substrate inside the reservoirs and create an electrical short circuit when wet.  
 
 After the fabrication of all features on the silicon wafer, a PSQ (Gelest, Morrisville, PA) 
coated silica wafer (500 µm thick) was used to seal the channels. PSQ has a similar chemistry to 
PDMS,  able to form covalent bonds with a silicon dioxide surface after plasma treatment and has 
been used for silicon/silica based device sealing previously [56,120,121]. PSQ was chosen over 
PDMS for our device because commercially-available PSQ has higher strength and is more 
amenable to dilution and spin coating. We used a PSQ sealing process adapted from that reported 
by Gu et al [120]. PSQ was diluted in xylene in a 3:2 ratio and then spin-coated on an oxygen 
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plasma cleaned silica wafer at 3000 RPM for 1 min. After spin-coating, the silica wafer was baked 
overnight at 150oC. The hard-baked silica wafer and processed silicon wafer were then O2 plasma 
treated at 100 W for 60 seconds in a YES-G500 Plasma Cleaning System (Yield Engineering 
Systems, Livermore, CA). The plasma power and time were crucial to properly activate the surface 
and form covalent bonds between two surfaces. We found that high-energy plasma damaged the 
structure of the PSQ and weakened wafer bonding. Similarly, long duration plasma exposure likely 
reduced the number of effective silanol groups via back-biting scission reactions. These two effects 
are well-known in PDMS plasma bonding processes [122]. This bonding process can be replaced 
by anodic bonding for scale-up [16,60]; at lab scale, PSQ mediated bonding is easier and faster. 
After plasma treatment, the two surfaces were brought in contact immediately. After wafer 
bonding, the wafer was diced into 1 cm by 1 cm chips as seen in Fig 4.2e, and then a thick layer 
of PDMS with 4 through-holes was bonded to the backside of the chip after a backside O2 plasma 




Fig 4.3. Fabrication of the nanofluidic device.  
(a) Schematic cross-section of fabrication process at the red line shown in Fig 4.2c. All channels 
and pillars were 6.5 µm tall and etched in one single DRIE step. (b)&(d) SEM of micropillars 
before HTO. (c)&(e) SEM of micropillars after HTO. The additional silicon dioxide layer 
increased the pillar size and reduced the nanogap size.  
 
4.4 Materials and Methods 
  
 For characterization experiments, Strep-647(Alexa-Fluor 647 conjugated streptavidin, 
Thermal Fisher Scientific, Waltham, MA) was used as the sample protein for preconcentration 
characterization in PBS (0.1X and 1X PBS, pH=7.4) solution. We also added 0.1% Tween-20 
(Thermo Fisher Scientific, Waltham, MA ) in all solutions in this paper to reduce non-specific 
binding on side walls. In the experiments that varied voltage (25V, 12.5V, 5V) and strep-647 
concentration (200ng/ml, 20ng/ml, 2ng/ml), we used 0.1X PBS (pH=7.4) with 0.1% Tween-20.  
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 For experiments employing fluorescent IL6, recombinant mouse IL6 (Thermo Fisher 
Scientific, Waltham, MA ) was labeled with Alexa-Fluor 488 using the Microscale Protein 
Labeling Kit (Thermo Fisher Scientific, Waltham, MA ). All labeled IL6 (IL6-488) 
preconcentration experiments were performed in 0.1X PBS (pH= 7.4,7.8,9) with 0.1% Tween-20 
at 25V. Sodium hydroxide (NaOH) were used to adjust the pH of 0.1X PBS solution. Both labeled 
and non-labeled IL6 were diluted in 0.1X PBS (pH=7.8) with 0.1% Tween-20 at 25V for bead-
based immunoassays, while a washing buffer was created with 1X PBS with 0.1% Tween-20. 
Strep-647 and detection antibody (BD Bioscience, San Jose, CA) were diluted in the washing 
buffer at the concentration of 2 µg/ml and 1 µg/ml, respectively, in immunoassays for non-labeled 
IL6. BSA-488 (Alexa Fluor 488 conjugated bovine serum albumin, Thermo Fisher Scientific, 
Waltham, MA) and BSA-647 (Alexa Fluor 647 conjugated bovine serum albumin, Thermo Fisher 
Scientific, Waltham, MA ) were used as tracers for non-labeled IL6 and labeled IL6, respectively. 
  
 Carboxyl group-coated polystyrene microbeads (~4.6 µm diameter, Spherotech,Lake 
Forest, IL) were conjugated with capture antibody of mouse IL6 by conventional EDC (1-Ethyl-
3-(3-dimethylaminopropyl)-carbodiimide, Thermo Fisher Scientific, Waltham, MA) and Sulfo-
NHS (N-hydroxysulfoxuccinimide, Thermo Fisher Scientific, Waltham, MA ) chemistry. Briefly, 
EDC and Sulfo-NHS were first dissolved in 0.05M MES buffer (Thermo Fisher Scientific, 
Waltham, MA) and immediately added to 0.5% w/v microbeads solution in DI water. The mixed 
solution was incubated for 15 min at room temperature, which was followed by centrifugation and 
wash in DI water with 0.1% Tween 20 in order to remove excessive EDC and Sulfo-NHS. Tween-
20 prevented microbeads from aggregating and adhering to centrifuge tube surfaces during 
centrifugation. Because Sulfo-NHS hydrolyzes in water spontaneously, the washing process had 
to be fast. After washing at least 3 times, anti-IL6 capture antibody (BD Biosciences, San Jose, 
CA ) was added into the microbead solution and incubated for 2 hrs at room temperature. Then, 
quencher solution, 50% w/v hydroxyl amine (Sigma-Aldrich, St. Louis, MO), was added into the 
mixture and incubated for another 10 min to deactivate the remaining NHS, after which the 
microbeads were washed again in DI water with 0.1% Tween-20. Before using the antibody 
conjugated microbeads, we blocked the microbeads by incubating in 1% BSA (bovine serum 
albumin, Thermo Fisher Scientific, Waltham, MA ) for 1 hr at room temperature.  
 
 All fluorescent images were taken on an inverted fluorescent microscope (Nikon Eclipse 
Ti, Nikon Instruments Inc, Melville, NY) with a CCD camera such that the anode was on the left 
side and the cathode on the right side of the image. Platinum wires (0.13mm in diameter, A-M 
System, Sequim, WA) were used as electrodes to apply voltage to each reservoir.  A waveform 
generator (Keysight,Santa Rosa, CA) connected to an amplifier (Tegam, Geneva, OH) was used 
to apply DC Voltage. ImageJ was used for image analysis.  
 
4.5 Results  
 
4.5.1 Lower ionic strength results in stronger enrichment 
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 We characterized the preconcentration phenomenon under different conditions in order to 
find the optimal ionic strength, voltage, and pH. Fig 4.4a shows the protein enrichment behavior 
under different ionic strengths of buffer solution (0.1X and 1X PBS). Strep-647 at a concentration 
of 200 ng/ml was used as the fluorescent tracer. When applying a 12.5 V DC voltage, we could 
observe the formation of an enrichment zone on the anodic (left) side of nanogaps. As soon as no 
voltage applied, accumulated strep-647 molecules easily leak through the nanogaps with positive 
pressure from anodic side. Note that the streptavidin molecules (~5 nm diameter [61]) are much 
smaller than the nanogaps: enrichment is caused by the development of ICP instead of size filtering. 
As shown in Fig 4.4a, detectable accumulation of strep-467 occurred after 1 min in 0.1X PBS, but 
was not detectable until 5 min in 1X PBS. After 10min, the intensity saturated in 0.1X PBS, while 
the intensity in 1X PBS was only approximately 30% of the saturated level.  
 
 
Fig 4.4 Characterization of protein enrichment.  
(a) Protein (200 ng/ml Strep-647) enrichment in different ionic strengths (0.1X & 1X PBS with 0.1% 
Tween-20). ICP based protein enrichment is much more effective in 0.1X PBS than in 1X PBS. A DC 
voltage of 12.5V was applied across the channels with anode on the left side and cathode on the right 
side. (b) Enrichment speed as a function of the applied DC voltage (5 V, 12.5 V and 25 V). Higher voltage 
leads to faster enrichment of 200 ng/ml Strep-647 solution. (c) Enrichment over 10min with various 
Strep-647 concentrations at 25V. (d) Closeup view for the 2ng/ml Strep-647 experiment in (c). Note the 
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4.5.2 Higher voltage leads to faster enrichment 
  
 We also investigated the preconcentration effect as a function of the applied DC voltage. 
Fig 4.4b shows that higher voltage leads to faster preconcentration. It took 600 s to achieve a 2000 
A.U intensity at 5 V, while it took approximately 240-260 s and 120 s at 12.5 V and 25 V, 
respectively, to reach the same intensity. In this voltage range, the enrichment speed is roughly 
proportional to the voltage, which is in agreement with the theoretical relationship between EOF 
and applied voltage.  
  
4.5.3 The preconcentrator achieves 1000-fold enrichment 
  
 After determining the optimal ionic strength and voltage, we characterized the enrichment 
phenomenon with various concentrations of strep-647. Fig 4.4c & 4.4d shows the preconcentration 
performance for strep-647 at 25 V in 0.1X PBS (pH=7.4) with 0.1% Tween-20. Fig 4.4c shows 
the enrichment of  strep-647 at initial concentrations of 200ng/ml, 20 ng/ml, and 2 ng/ml over 10 
min. During the preconcentration, one fluorescent image was taken every minute. Between image 
captures, the shutter for the excitation light was closed to prevent photobleaching. Fig 4.4d is a 
closer look at the 2ng/ml group in Fig 4.4c; for reference, the horizontal dashed line represents the 
signal intensity of a 2 µg/ml strep-647 solution. As we concentrated the proteins, the fluorescent 
intensity of the initially 2 ng/ml solution increased and exceeded the intensity level of the 2 µg/ml 
reference within 10 min; this is indicative of a 1000-fold enrichment. 
 
4.5.4 IL6 can be enriched with pH adjustment 
  
 Before integrating immunoassays into our device, we used IL6-488 to demonstrate that the 
preconcentrator could enrich not only streptavidin but also IL6. However, there was no enrichment 
of IL6-488 in 0.1X PBS at pH=7.4, as shown in Fig 4.5a. The IL6-488 enrichment was then tested 
at higher pH (pH= 7.8, 9). Because the IL6 molecules are more negatively charged at higher pH, 
we expected them to accumulate more easily within the depletion zone(Fig 4.5a). Note that the 
antigen-antibody reaction is negatively affected by higher pH (pH > 8), which reduces the affinity 
of antibodies [69]. We tested the antibody activity by incubating IL6 with antibody-conjugated 
beads at various pH(pH=7.4, 7.8, 9). For the same concentration of IL6, the signal intensity on 
beads was at least 60% lower at pH=9 compared to that at pH=7.4 due to the lower affinity of the 
antibody at higher pH(Fig 4.6). Thus, for all of the following immunoassays, we chose the lowest 
pH (pH=7.8) that promoted enrichment but did not reduce intensity below about 90% of the 
intensity observed at pH 7.4. 
 
4.5.5 BSA-647 is a good fluorescent tracer for IL6 preconcentration 
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 In order to monitor the development of ICP and an enrichment zone in the IL6 
immunoassay, we used a fluorescent tracer for IL6.  We required a fluorescent tracer that 1) 
enriched along with IL6, 2) accumulated at the same location as IL6, and 3) did not interfere with 
other reagents in the immunoassay. As shown in Fig 4.5b, when enriched simultaneously along 
with IL6-488 in the same solution, BSA-647 enrichment zone was colocalized with the enrichment 





Fig 4.5 BSA is a good tracer for IL6 preconcentration.  
(a) The enrichment performance of IL6-488 under various pH. Sample solution (0.1X PBS, 0.1% 
Tween-20, 2µg/ml IL6-488 at pH= 7.4, 7.8, 9) was loaded into the device and 25V was applied 
to the reservoirs for 10min. (b) BSA-647 could be used as a good tracer for IL6 enrichment. 
Both BSA-647 (200 ng/ml) and IL6-488 (2 µg/ml) were enriched simultaneously at 25V in the 
same sample solution as (a) except the pH=7.8. The enrichment zone of BSA-647 was highly 
colocalized with the enrichment zone of IL6-488. To maintain the activity of IL6, we used a low 
degree of labeling for IL6-488 (less fluorescent molecules per protein molecule). Thus, we used 
10 times higher concentration of IL6-488 than BSA-647 for characterization experiments.   




Fig 4.6 Higher pH negatively affects antibody-antigen reaction.  
In this experiment, microbeads were incubated with 200 ng/ml non-labeled IL6 for 2 hr, 
followed by the incubation in detection antibody and strep-647, respectively. The IL6 solutions 
were prepared at different pH. The intensity of microbeads at pH=9 is more than 60% lower 
than that at pH=7.4.  
 
 
4.5.6 Nanogap preconcentrator enables bead-based immunoassays 
 
 To demonstrate the compatibility of this method with bead-based immunoassays, we 
conjugated polystyrene microbeads (4.6 µm in diameter) with rat anti-mouse IL6 capture antibody. 
Since the microbeads were smaller than the height of the microchannels but much larger than the 
nanogaps, all microbeads were stopped at the pillars. Smaller beads (100 nm – 2 µm in diameter, 
data not shown) also stopped at the pillars, but we chose ~4.6 µm diameter beads because the 
larger size provided better observation and control over the number of beads per microchannel. In 
addition, beads with submicron size could potentially partially block the nanogaps and decrease 
the effective nanogap size, which would significantly affect enrichment behavior. 
 
 The immunoassay process is shown in Fig 4.7. First, approximately five microbeads were 
loaded into each microchannel, followed by the loading of IL6-488 sample solution. DC voltage 
was applied for 10 min at 25 V. Note, similar to other ICP based 
preconcentrators[60,61,64,65,71,72,74,146], we also observed vortical flow in the depletion 
region so that microbeads moved along with the vortical flow during enrichment. The location of 
microbeads in Fig 4.7c & 5d is , therefore, different from the location in Fig 4.7a. The microbeads 
were incubated for five minutes after turning off the voltage (Fig 4.7b & 4.7c). Since the nanogaps 
restricted diffusion, IL6-488 diffusion was slower in the nanostructures than in an open 
microchannel (where molecules can diffuse freely in both directions). Thus, after a 5 min 
incubation, the elevated fluorescent signal (Fig 4.7c) was ~75% lower than the signal immediately 
after turning off the voltage (Fig 4.7b), but it was still more than 50x higher than the background. 
This result demonstrated that without additional convection, IL6 molecules did not diffuse away 
immediately. This additional 5 min incubation improved antigen-antibody binding and noticeably 
enhanced signal intensity [72], after which a positive pressure was applied through anodic side to 
wash away excessive fluorescent molecules (Fig 4.7d) .  
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Fig 4.7 Immunoassay procedures for IL6-488.  
(a) Bead loading (~5 microbeads per microchannel) and preconcentration of IL6-488 at 25V 
for 10 min in sample solution (0.1X PBS, 1% Tween-20, 500 ng/ml IL6-488, pH=7.8). 
Immediately after turning off the voltage (b), the enrichment molecules started diffusing away 
toward both sides. Since the nanogaps restricted diffusion, the diffusion to right side was slower. 
Thus, even 5 min after turning off the voltage, a higher (50X higher than background) 
fluorescent signal was detectable in front of the nanostructure (c), although it was ~75% weaker 
than the signal immediately after turning off the voltage (b). (d) After 5min incubation, a positive 




 The detection of non-labeled IL6 uses the same process as IL6-488 detection, except that 
biotin conjugated detection antibody and strep-647 were loaded after loading IL6. An additional 
washing step was necessary between the loading of detection antibody and strep-647, since the 
mixture of these two reagents might induce micro-aggregation and block the nanogaps. The dose 
response curves of both labeled and non-labeled IL6 are shown in Fig 4.8. Two inset fluorescence 
images show the saturated signals for each case. Fluorescent signals were normalized using the 
saturated signal and zero dose signal as 100% and 0% intensity. We used the four parameter 
logistic model in Eq. 1 to fit the dose response curves which models the physicochemical 
mechanism of antigen-antibody binding 
 
                                           y = d + %&'()(+,).                                           Eq.1 
 
 where y is the fluorescent intensity, x is the target concentration, d represents the intensity at 
infinite concentration, a is the estimated intensity at zero concentration of target, b is the Hill 
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coefficient referring to the steepness of the curve, and c is the midrange concentration [71,147].  





Fig 4.8. Dose response of the immunoassay with and without preconcentration. 
Immunoassays for (a) IL6-488 and (b) non-labeled IL6 were performed on beads with (green 
curve) and without (blue curve) enrichment. The sensitivity of IL6-488 and non-labeled IL6 
detection was enhanced ~125 fold and ~162 fold, respectively. The in-plot fluorescence images 
show saturated signals for IL6-488 (a) and non-labeled IL6 (b). Both labeled and non-labeled 
IL6 preconcentration was conducted with the same sample solution (0.1X PBS, 1% Tween-20, 
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deviations above the background signal was used to define the limit of detection (LOD). Using 
these curves, the LOD of labeled and non-labeled IL6 without enrichment was 15ng/ml and 
1.2ng/ml, respectively. After 10 min enrichment, the LOD of labeled and non-labeled IL6 was 
enhanced to 120 pg/ml (~125 fold improvement) and 7.4pg/ml (~162 fold improvement), which  
is comparable to the 500 fold enhancement in 60 min (30 min enrichment plus 30 min additional  




 The weaker enrichment observed for 1X PBS vs.  0.1X PBS (Fig 4.4a) is likely due to the 
higher ionic strength of the solution. A higher ionic strength solution would exhibit a thinner EDL 
and, therefore, slower electroosmotic flow (assuming the same DC voltage applied) and a smaller 
ratio of surface conductivity to bulk conductivity. Thus, it takes longer to develop a low 
concentration region near the nanogaps and accumulate target molecules. Interestingly, no 
fluorescent signal was found for 0.01X PBS. One possible reason is that this much lower ion 
concentration promotes strong ICP immediately and a depletion zone develops which is longer 
than the microchannel, preventing protein enrichment. 
  
 Also of interest is that for voltages  of 5 - 25V, the enrichment rate of our preconcentrator 
is proportional to the voltage, because higher electric potential results in higher electroosmotic 
flow rate. Electroosmotic flow is the principal effect bringing proteins to the enrichment zone from 
bulk areas. Thus, a higher electroosmotic flow rate accelerates the protein accumulation process. 
However, if the voltage is too low (< 2V), the depletion zone did not fully develop and was not 
effective at preventing analytes from moving downstream [62]. When the voltage was higher than 
50 V, the EOF overwhelmed the ICP-based enrichment so the enrichment zone became unstable. 
Consequently, strep-647 molecules leaked through nanogaps frequently. In addition, when the 
voltage was very high (>100 V), background proteins (such as the BSA used in the immunoassays 
in section 3.6) started to aggregate and to block the nanogaps (Fig 4.9). This may be due to pH 
changes [148] or ohmic heating [149–152] but further investigation is needed to be certain. 
  
 Unlike Strep-647 (pI ~5.5 [153]), IL6-488 (pI ~6.96 [154]) could not be enriched at pH 7.4. 
We believe this is because the pI value of mouse IL6 is very close to the pH of PBS (pH=7.4); 
thus, mouse IL6 molecules are either not charged or weakly charged in PBS. According to the 
mechanism of ICP-based enrichment, neutral molecules cannot be trapped efficiently in front of 
the depletion zone [61]. In contrast, IL6-488 was successfully enriched at higher pH (pH = 7.8, 9). 
There are two possible reasons. First, more silanol groups on silica surface are deprotonated in 
higher pH [155]. The higher charge density on nanogap surfaces leads to higher surface 
conductivity, which enhances ICP development. Second, the higher pH also leads to more 
pH=7.8), DC voltage (25 V) and duration (10 min). BSA-647 or BSA-488 (200 ng/ml) was used 
as the tracer protein and simulated molecular background for labeled and non-labeled IL6, 
respectively. Both of the non-enrichment groups were incubated in tubes for 2 hrs at room 
temperature in the same sample solution.   
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negatively charged IL6-488 molecules, so that the depletion zone can trap IL6-488 molecules more 
efficiently, preventing them moving downstream [1].  At pH=9, the enrichment zone was 
approximately 450µm away from the nanostructure (Fig 4.5a), which was only 36µm at pH=7.8. 
This is likely due to higher surface charge density producing stronger ICP development and the 
depletion zone propagating further at pH=9. In addition, increasing pH increases the 
electrophoretic mobility of protein molecules (i.e. more negatively charged at higher pH), so that 
the vortical flows carry these molecules further back to the location of lower electric field, where 




Fig 4.9 Protein aggregation induced by high voltage.  
This experiment was conducted with the same immunoassay process described in the paper, 
except that the DC voltage used for enrichment was 100 V. Yellow arrow point at beads and 
white arrows indicate the protein aggregates. Nanostructure should be non-fluorescent. We 
can see the nanostructure in this image because the nanochannels were completely blocked by 




 Lastly, the saturated signal for non-labeled IL6 (Fig 4.8b inset image) was much higher 
than the saturated signal for labeled IL6 (Fig 4.8a inset image). There are three possible reasons 
for this. First, since each detection antibody molecule has multiple biotin sites and each strep-647 
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molecule has multiple fluorophores, this combination amplifies the signal. Second, we used a 
lower degree of labeling for IL6 so there were fewer fluorophores per IL6 molecule. Third, the 
labeled IL6 and non-labeled IL6 used different fluorescent molecules for detection. The Alexa 
Fluor 647 on Strep-647 (for non-labeled IL6) is generally brighter than the Alexa Fluor 488 on 
IL6-488.  
  
 Although we successfully enriched IL6 and enhanced the sensitivity by more than 2 orders 
of magnitude, the sensitivity enhancement factor was still lower than the concentration factor, 
which was at least 1000 times greater than initial concentration. This might be result of the local 
pH change, ohmic heating and the change in buffer ionic strength during preconcentration [72]. 




 In summary, we demonstrated the use of nanogaps fabricated between micropillars to 
mimic a semi-permselective membrane for the purpose of ICP-based target molecule 
preconcentration. Since the nanogaps have a high ratio of surface conductivity to bulk conductivity, 
ICP based protein preconcentration was generated on the anodic side of the micropillars. The large 
number of short vertical nanogaps allowed sufficient volumetric flow for bead loading and 
washing, which is not possible for conventional horizontal nanochannels. This structure is 
comparable in performance to preconcentration microchannel designs using Nafion film [72] but 
is more amenable to large scale fabrication. We also demonstrated a preconcentration-enhanced 
immunoassay for the detection of IL6. This structure and preconcentration mechanism can be 
useful to improve the efficiency and the multiplexing capability of silicon/silica based 
preconcentrators. The performance of this device can be tuned by increasing the number or 
changing the dimensions of the pillars without changing the fabrication process. We expect this 
assay can be used for a broad range of analytes and a variety of detection methods. For example, 
this device can be combined with faster label-free detection methods to further speed up assays 
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Chapter 5: Conclusions and Future Outlook 
 
 
Miniaturized biomolecular detection is a fast-growing field that has been extensively 
studied over the past couple decades. With the advances in micro- and nano-fabrication techniques, 
microfluidic devices have acquired many advantages over laboratory-scale equipment such as fast 
detection, minimal consumption of samples, compatibility with portable diagnostic solutions, high 
efficiency, and low cost. Microfluidic biomolecular detection is particularly important in disease 
diagnostics, improving the effectiveness of treatment and human life expectancy. However, many 
low abundant biomarkers such as early stage cancer biomarkers and cytokines often demand an 
extremely low LOD. Thus, a rapid biomolecular detection with low LOD is highly desirable for 
disease diagnostics.  
 
Most immunoassays demand the use of antibodies and miniaturized devices require precise 
and submicron-scale antibody immobilization onto the biosensing surfaces. In this thesis, we first 
demonstrated a new protein nanopatterning technique using Ge as a sacrificial layer, which is 
compatible with conventional fabrication tools and suitable for low cost and high volume 
manufacturing of miniaturized biosensors. This technique is of particular utility for surface 
conjugation chemistries with organic solvents. We reported protein patterning with two different 
methods of Ge deposition: e-beam evaporation and LPCVD. Sidewall functionalization can be 
achieved and controlled by using a non-conformal Ge deposition process such as e-beam 
evaporation, while the Ge films deposited by LPCVD are more conformal and can avoid protein 
immobilization on sidewalls, which may be preferred for some biosensor applications.  
 
 Then, we introduced ICP as the mechanism for rapid analyte enrichment in order to 
improve the sensitivity of immunoassays without prolonged incubations. The first version 
preconcentrator was developed on silica substrates using ICP induced enrichment. We improved 
the performance of our devices from a single 300 nm deep nanochannel to hundreds of 6.5 µm 
deep nanochannels, from silica substrates to silicon substrates, from surface-based immunoassays 
to bead-based immunoassays, and from fluorescent streptavidin enrichment to natural IL6 
molecules detection. Finally, we showed an ICP-based preconcentrator using hundreds of vertical 
nanochannels to mimic a perm-selective membrane for analyte preconcentration. The channels on 
the device are straightforward to fabricate and scalable using conventional lithography tools. The 
large number of short vertical nanochannels allows sufficient volumetric flow for bead loading 
and washing directly through nanochannels, which is not possible for conventional horizontal 
nanochannels. The final device is capable of enriching protein molecules by more than 1000 fold 
in 10min and detecting IL6 down to 7.4pg/ml with only a 10 min enrichment followed by a 5 min 
incubation. This is a 162-fold enhancement in sensitivity compared to that without enrichment. 
 
 Our device has comparable performance with the ICP enhanced immunoassay devices 
using Nafion film[72]. This structure and preconcentration mechanism can be useful to improve 
the efficiency and the multiplexing capability of silicon/silica based preconcentrators. The 
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performance of this device can be tuned easily by increasing the number or changing the 
dimensions of the pillars without changing the fabrication process.   
 
  To move this ICP-based technology towards commercialization and eventual use in the 
clinic, we need a more fundamental understanding of ICP mechanisms. Both additional 
understanding of all of the underlying processes at work and mathematical models of ICP are 
necessary for further development of this technology. Most ICP modeling results have the 
nanochannel perpendicular to microchannels, so the modeling specifically for this nanogap-design 
will be tremendously helpful to apply this ICP mechanism in more biosensing systems. For 
example, one of the challenging problems is the instability of the concentration plug. In our hands, 
enrichment zones were not stable under high voltage, long enrichment time, and complex 
biological solutions. This instability might be due to various factors, including dynamic pH 
changes, ohmic heating, biomolecule aggregation, and nanogap blockage. Mitigating this 
instability is critical for future development and commercialization of ICP-based preconcentration 
devices.  
  
 With regards to our specific design, several areas deserve additional attention. First, 
fabricating robust nanogaps (or permselective membranes) with high yield remains challenging. 
Second, enrichment required low ionic strength (~15mM) solutions. It would be preferable to 
modify the method to enable preconcentration in high ionic strength (>100mM) solution or serum 
samples. Third, nanogaps would sometimes block, generating instabilities which could be 
compensated by the researcher but required feedback. Lastly, as mentioned above, we noticed that 
the enrichment zones often became unstable and moved away from their designed location, making 
detection difficult.   
 
 Once fully developed, we expect ICP-based enrichment to be used in more assays with a 
broad range of analytes. The mechanism of ICP can only accumulate charged molecules. However, 
most clinical analytes have charge at physiological pH, so ICP-based preconcentration can be 
utilized for most biological analytes in the fields of healthcare, food industry, and environmental 
monitoring[1][61]. In addition, this preconcentration technique can be incorporated with other 
biosensing techniques to boost the performance of those other techniques. For example, this device 
could be combined with label-free detection methods (for example, electrochemical detection 
methods [56,156] ) to speed up those assays. 
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